| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | NID2 HSPG2 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 SSPOP FBN1 FBN2 HMCN1 MEGF9 MUC2 MUC4 TNXB FBN3 | 2.98e-21 | 188 | 100 | 20 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | CACNA1E NID2 HSPG2 FAT4 STAB2 NOTCH2NLA VWCE NOTCH2NLC TENM2 F12 CRB1 STAB1 JAG2 SNED1 FBN1 FBN2 PROZ SCUBE2 EGF HMCN1 MEGF6 SUSD1 SLIT3 DLL3 EGFLAM LTBP3 FBN3 NOTCH1 NOTCH3 CRB2 | 2.32e-19 | 749 | 100 | 30 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | GPM6B NID2 HSPG2 COL7A1 FRAS1 COL16A1 OBSCN LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 SSPOP FBN1 FBN2 HMCN1 MEGF9 MUC2 MUC4 TNXB FBN3 | 4.05e-10 | 891 | 100 | 22 | GO:0005198 |
| GeneOntologyMolecularFunction | integrin binding | 1.81e-08 | 175 | 100 | 10 | GO:0005178 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | COL16A1 OBSCN LAMA5 LAMB1 LAMB2 ITGB4 TENM2 ITGB6 ITGBL1 FBN1 TENM4 TENM3 TNN TENM1 TNXB NOTCH3 | 4.60e-08 | 599 | 100 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | Notch binding | 2.11e-07 | 27 | 100 | 5 | GO:0005112 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 6.08e-05 | 268 | 100 | 8 | GO:0005539 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.51e-05 | 16 | 100 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 7.42e-05 | 3 | 100 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | palmitoyl-CoA ligase activity | 7.42e-05 | 3 | 100 | 2 | GO:0090433 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.52e-04 | 21 | 100 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | histone H3K27 methyltransferase activity | 3.68e-04 | 6 | 100 | 2 | GO:0046976 | |
| GeneOntologyMolecularFunction | histone H3K9 monomethyltransferase activity | 6.82e-04 | 8 | 100 | 2 | GO:0140948 | |
| GeneOntologyMolecularFunction | histone H3K9me2 methyltransferase activity | 1.09e-03 | 10 | 100 | 2 | GO:0140947 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 1.33e-03 | 11 | 100 | 2 | GO:0047676 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.39e-03 | 44 | 100 | 3 | GO:0140938 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.59e-03 | 12 | 100 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | histone H3K9 methyltransferase activity | 1.87e-03 | 13 | 100 | 2 | GO:0046974 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.17e-03 | 14 | 100 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 2.50e-03 | 15 | 100 | 2 | GO:0004467 | |
| GeneOntologyMolecularFunction | heparin binding | 2.81e-03 | 192 | 100 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | C2H2 zinc finger domain binding | 3.22e-03 | 17 | 100 | 2 | GO:0070742 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 3.61e-03 | 18 | 100 | 2 | GO:0030169 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HSPG2 FAT4 FRAS1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 PGR CRB1 JAG2 MST1 FBN2 SCUBE2 TENM3 MEGF9 SLIT3 LRP6 LTBP3 MST1L ASB2 MEGF11 NOTCH1 CRB2 | 4.86e-11 | 1269 | 101 | 27 | GO:0009887 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 7.73e-10 | 63 | 101 | 8 | GO:0007157 | |
| GeneOntologyBiologicalProcess | axon guidance | HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 SEMA3D MEGF9 SLIT3 NOTCH1 NOTCH3 | 1.40e-09 | 285 | 101 | 13 | GO:0007411 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | GPM6B NID2 COL16A1 LAMA5 LAMB1 LAMB2 ITGB4 ITGB6 SNED1 ITGBL1 TNN EGFLAM MUC4 TNXB NOTCH1 | 1.45e-09 | 410 | 101 | 15 | GO:0031589 |
| GeneOntologyBiologicalProcess | neuron projection guidance | HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 SEMA3D MEGF9 SLIT3 NOTCH1 NOTCH3 | 1.47e-09 | 286 | 101 | 13 | GO:0097485 |
| GeneOntologyBiologicalProcess | neuron development | GPM6B HSPG2 FAT4 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 GRXCR1 TENM2 CRB1 ACSL4 SEMA3D TENM4 TENM3 MEGF9 OTOGL TNN SLIT3 TENM1 LRP6 TNXB NOTCH1 NOTCH3 CRB2 | 5.57e-09 | 1463 | 101 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 2.96e-08 | 99 | 101 | 8 | GO:0045995 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.72e-07 | 124 | 101 | 8 | GO:0007229 | |
| GeneOntologyBiologicalProcess | neuron projection development | GPM6B HSPG2 FAT4 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 GRXCR1 TENM2 ACSL4 SEMA3D TENM3 MEGF9 OTOGL TNN SLIT3 LRP6 TNXB NOTCH1 NOTCH3 | 2.05e-07 | 1285 | 101 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | GPM6B NID2 HSPG2 COL7A1 COL16A1 LAMA2 LAMB1 LAMB2 HMCN1 EGFLAM TNXB NOTCH1 | 3.23e-07 | 377 | 101 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | GPM6B NID2 HSPG2 COL7A1 COL16A1 LAMA2 LAMB1 LAMB2 HMCN1 EGFLAM TNXB NOTCH1 | 3.32e-07 | 378 | 101 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | GPM6B NID2 HSPG2 COL7A1 COL16A1 LAMA2 LAMB1 LAMB2 HMCN1 EGFLAM TNXB NOTCH1 | 3.41e-07 | 379 | 101 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | axon development | GPM6B HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 SEMA3D MEGF9 TNN SLIT3 NOTCH1 NOTCH3 | 5.30e-07 | 642 | 101 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 SEMA3D MEGF9 TNN SLIT3 NOTCH1 NOTCH3 | 6.70e-07 | 566 | 101 | 14 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 8.44e-07 | 270 | 101 | 10 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | FAT4 LAMA3 LAMB1 ITGB4 TENM2 ITGB6 CRB1 ITGBL1 TENM4 HMCN1 TENM3 TENM1 LRP6 MUC4 TNXB MEGF11 NOTCH1 CRB2 PEAR1 | 1.03e-06 | 1077 | 101 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | basement membrane organization | 2.12e-06 | 43 | 101 | 5 | GO:0071711 | |
| GeneOntologyBiologicalProcess | female pregnancy | 3.75e-06 | 249 | 101 | 9 | GO:0007565 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 7.96e-06 | 147 | 101 | 7 | GO:0030278 | |
| GeneOntologyBiologicalProcess | embryo implantation | 8.18e-06 | 97 | 101 | 6 | GO:0007566 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 9.08e-06 | 210 | 101 | 8 | GO:0007219 | |
| GeneOntologyBiologicalProcess | gliogenesis | GPM6B MBOAT7 LAMA2 LAMB1 LAMB2 ITGB4 CRB1 TENM4 DLL3 LRP6 NOTCH1 | 9.36e-06 | 435 | 101 | 11 | GO:0042063 |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 1.03e-05 | 59 | 101 | 5 | GO:0085029 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | GPM6B HSPG2 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 JAG2 TENM3 TNN ZFHX3 EGFLAM MUC4 TNXB NOTCH1 | 1.08e-05 | 927 | 101 | 16 | GO:0030155 |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 1.28e-05 | 290 | 101 | 9 | GO:0044703 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 1.43e-05 | 294 | 101 | 9 | GO:0044706 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 SEMA3D MEGF9 TNN SLIT3 NOTCH1 NOTCH3 | 1.67e-05 | 748 | 101 | 14 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of ossification | 1.80e-05 | 66 | 101 | 5 | GO:0045778 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.83e-05 | 11 | 101 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 2.85e-05 | 321 | 101 | 9 | GO:0010001 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | HSPG2 STAB2 MBOAT7 OBSCN ITGB4 ITGB6 CRB1 STAB1 FBN2 TENM4 EGF TNN DLL3 NR0B1 LRP6 TM4SF1 MEGF11 NOTCH1 NOTCH3 CRB2 | 2.88e-05 | 1483 | 101 | 20 | GO:0048646 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 SEMA3D MEGF9 TNN SLIT3 NOTCH1 NOTCH3 | 3.59e-05 | 802 | 101 | 14 | GO:0048812 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.99e-05 | 14 | 101 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 SEMA3D MEGF9 TNN SLIT3 NOTCH1 NOTCH3 | 4.51e-05 | 819 | 101 | 14 | GO:0120039 |
| GeneOntologyBiologicalProcess | bone development | 4.69e-05 | 264 | 101 | 8 | GO:0060348 | |
| GeneOntologyBiologicalProcess | skeletal system development | HSPG2 FAT4 LAMA5 ITGB6 JAG2 FBN1 FBN2 SCUBE2 TNN DLL3 LRP6 LTBP3 | 4.71e-05 | 615 | 101 | 12 | GO:0001501 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 SEMA3D MEGF9 TNN SLIT3 NOTCH1 NOTCH3 | 4.94e-05 | 826 | 101 | 14 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 5.79e-05 | 84 | 101 | 5 | GO:1903053 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | HSPG2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 TENM2 ITGB6 CRB1 SEMA3D MEGF9 TNN SLIT3 LRP6 NOTCH1 NOTCH3 | 6.48e-05 | 1194 | 101 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | mammary gland duct morphogenesis | 6.92e-05 | 45 | 101 | 4 | GO:0060603 | |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 8.05e-05 | 90 | 101 | 5 | GO:0060042 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 8.49e-05 | 91 | 101 | 5 | GO:0033627 | |
| GeneOntologyBiologicalProcess | cerebral cortex development | 8.59e-05 | 147 | 101 | 6 | GO:0021987 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.09e-04 | 96 | 101 | 5 | GO:0060113 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 1.32e-04 | 53 | 101 | 4 | GO:0045747 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.42e-04 | 4 | 101 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | forebrain development | FAT4 MBOAT7 NOTCH2NLA LAMB1 NOTCH2NLC SLIT3 NR0B1 LRP6 NOTCH1 NOTCH3 | 1.43e-04 | 489 | 101 | 10 | GO:0030900 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.53e-04 | 313 | 101 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.60e-04 | 104 | 101 | 5 | GO:0042490 | |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.88e-04 | 23 | 101 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | embryo development | HSPG2 FRAS1 GGNBP2 LAMA2 LAMA3 LAMA5 JAG2 ACSL4 FBN2 TENM4 DLL3 NR0B1 EHMT1 LRP6 ASB2 TM4SF1 NOTCH1 CRB2 | 1.96e-04 | 1437 | 101 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.97e-04 | 171 | 101 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.24e-04 | 619 | 101 | 11 | GO:0002009 | |
| GeneOntologyBiologicalProcess | central nervous system development | GPM6B HSPG2 FAT4 MBOAT7 NOTCH2NLA LAMB1 LAMB2 NOTCH2NLC TENM4 EGF SLIT3 DLL3 NR0B1 LRP6 NOTCH1 NOTCH3 | 2.25e-04 | 1197 | 101 | 16 | GO:0007417 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 2.25e-04 | 421 | 101 | 9 | GO:0060562 | |
| GeneOntologyBiologicalProcess | compartment pattern specification | 2.35e-04 | 5 | 101 | 2 | GO:0007386 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine dimethylation | 2.35e-04 | 5 | 101 | 2 | GO:0018027 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 2.38e-04 | 334 | 101 | 8 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 2.38e-04 | 334 | 101 | 8 | GO:0001894 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 2.44e-04 | 178 | 101 | 6 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of biomineral tissue development | 2.45e-04 | 114 | 101 | 5 | GO:0070167 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 2.45e-04 | 114 | 101 | 5 | GO:0008593 | |
| GeneOntologyBiologicalProcess | epithelium development | FAT4 FRAS1 CNFN LAMA5 LAMB2 GRXCR1 PGR JAG2 MST1 EGF DLL3 NR0B1 LRP6 MST1L ASB2 MUC2 NOTCH1 CRB2 | 2.56e-04 | 1469 | 101 | 18 | GO:0060429 |
| GeneOntologyBiologicalProcess | mammary gland morphogenesis | 2.92e-04 | 65 | 101 | 4 | GO:0060443 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FAT4 FRAS1 LAMA5 PGR JAG2 MST1 EGF LRP6 MST1L ASB2 NOTCH1 CRB2 | 3.01e-04 | 750 | 101 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | segmentation | 3.49e-04 | 123 | 101 | 5 | GO:0035282 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 3.52e-04 | 6 | 101 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | hemidesmosome assembly | 3.52e-04 | 6 | 101 | 2 | GO:0031581 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 3.52e-04 | 6 | 101 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 3.75e-04 | 125 | 101 | 5 | GO:0046425 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 4.32e-04 | 198 | 101 | 6 | GO:0007259 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 4.32e-04 | 198 | 101 | 6 | GO:0048754 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 4.32e-04 | 72 | 101 | 4 | GO:0022029 | |
| GeneOntologyBiologicalProcess | ossification | 4.34e-04 | 562 | 101 | 10 | GO:0001503 | |
| GeneOntologyBiologicalProcess | tube development | HSPG2 FAT4 STAB2 LAMA5 ITGB6 PGR STAB1 MST1 FBN1 EGF TNN LRP6 LTBP3 MST1L ASB2 NOTCH1 NOTCH3 | 4.39e-04 | 1402 | 101 | 17 | GO:0035295 |
| GeneOntologyBiologicalProcess | biomineral tissue development | 4.92e-04 | 203 | 101 | 6 | GO:0031214 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 5.04e-04 | 75 | 101 | 4 | GO:0021885 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 5.04e-04 | 75 | 101 | 4 | GO:0048286 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 5.05e-04 | 204 | 101 | 6 | GO:0048592 | |
| GeneOntologyBiologicalProcess | somitogenesis | 5.30e-04 | 76 | 101 | 4 | GO:0001756 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 6.03e-04 | 211 | 101 | 6 | GO:0060041 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 6.52e-04 | 8 | 101 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | response to fungicide | 6.52e-04 | 8 | 101 | 2 | GO:0060992 | |
| GeneOntologyBiologicalProcess | gastrulation with mouth forming second | 6.66e-04 | 35 | 101 | 3 | GO:0001702 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 6.75e-04 | 299 | 101 | 7 | GO:0060560 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 6.82e-04 | 216 | 101 | 6 | GO:0097696 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 6.94e-04 | 143 | 101 | 5 | GO:1904892 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | HSPG2 FRAS1 LAMA5 JAG2 FBN2 TENM4 NR0B1 LRP6 ASB2 NOTCH1 CRB2 | 7.35e-04 | 713 | 101 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | respiratory system development | 7.58e-04 | 305 | 101 | 7 | GO:0060541 | |
| GeneOntologyBiologicalProcess | mammary gland epithelium development | 7.74e-04 | 84 | 101 | 4 | GO:0061180 | |
| GeneOntologyBiologicalProcess | pallium development | 7.87e-04 | 222 | 101 | 6 | GO:0021543 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | LAMA2 LAMA3 LAMA5 LAMB1 LAMC2 PGR MST1 SEMA3D FBN2 EGF TNN MST1L MUC2 TNXB NOTCH1 | 7.95e-04 | 1211 | 101 | 15 | GO:0030334 |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 8.36e-04 | 9 | 101 | 2 | GO:0003344 | |
| GeneOntologyBiologicalProcess | positive regulation of mammary gland epithelial cell proliferation | 8.36e-04 | 9 | 101 | 2 | GO:0033601 | |
| GeneOntologyBiologicalProcess | mammary duct terminal end bud growth | 8.36e-04 | 9 | 101 | 2 | GO:0060763 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway involved in heart development | 8.36e-04 | 9 | 101 | 2 | GO:0061311 | |
| GeneOntologyBiologicalProcess | odontogenesis | 8.86e-04 | 151 | 101 | 5 | GO:0042476 | |
| GeneOntologyBiologicalProcess | sensory organ development | FAT4 LAMB2 GRXCR1 CRB1 JAG2 TENM3 OTOGL LRP6 MEGF11 NOTCH1 CRB2 | 8.92e-04 | 730 | 101 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 9.48e-04 | 514 | 101 | 9 | GO:0050678 | |
| GeneOntologyBiologicalProcess | brain development | HSPG2 FAT4 MBOAT7 NOTCH2NLA LAMB1 NOTCH2NLC EGF SLIT3 NR0B1 LRP6 NOTCH1 NOTCH3 | 1.00e-03 | 859 | 101 | 12 | GO:0007420 |
| GeneOntologyCellularComponent | extracellular matrix | NID2 HSPG2 LAMB4 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 MUC5B SSPOP ITGB4 F12 MST1 SNED1 FBN1 FBN2 FCGBP HMCN1 MEGF6 MEGF9 OTOGL TNN EGFLAM LTBP3 MUC2 MUC4 TNXB FBN3 | 7.18e-24 | 656 | 100 | 32 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NID2 HSPG2 LAMB4 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 MUC5B SSPOP ITGB4 F12 MST1 SNED1 FBN1 FBN2 FCGBP HMCN1 MEGF6 MEGF9 OTOGL TNN EGFLAM LTBP3 MUC2 MUC4 TNXB FBN3 | 7.88e-24 | 658 | 100 | 32 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NID2 HSPG2 LAMB4 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 SSPOP ITGB4 F12 MST1 FBN1 FBN2 HMCN1 MEGF6 MEGF9 TNN EGFLAM LTBP3 MUC2 MUC4 TNXB | 1.45e-20 | 530 | 100 | 27 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | NID2 HSPG2 LAMB4 COL7A1 FRAS1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 FBN1 HMCN1 MEGF9 EGFLAM | 5.86e-19 | 122 | 100 | 16 | GO:0005604 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 3.74e-10 | 59 | 100 | 8 | GO:0098636 | |
| GeneOntologyCellularComponent | laminin complex | 5.60e-10 | 10 | 100 | 5 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.34e-08 | 17 | 100 | 5 | GO:0098637 | |
| GeneOntologyCellularComponent | laminin-5 complex | 4.23e-07 | 4 | 100 | 3 | GO:0005610 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.81e-05 | 33 | 100 | 4 | GO:0043083 | |
| GeneOntologyCellularComponent | laminin-2 complex | 2.27e-05 | 2 | 100 | 2 | GO:0005607 | |
| GeneOntologyCellularComponent | microfibril | 2.93e-05 | 13 | 100 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | laminin-10 complex | 6.78e-05 | 3 | 100 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 6.78e-05 | 3 | 100 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-3 complex | 6.78e-05 | 3 | 100 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | tenascin complex | 1.35e-04 | 4 | 100 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.79e-04 | 109 | 100 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | subapical complex | 2.24e-04 | 5 | 100 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | integrin complex | 4.76e-04 | 32 | 100 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.21e-03 | 11 | 100 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1E HSPG2 SSPOP ITGB4 ITGB6 CRB1 ITGBL1 LRP6 KCNMB3 CRB2 | 4.34e-03 | 785 | 100 | 10 | GO:0098797 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 5.24e-03 | 332 | 100 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | mitochondria-associated endoplasmic reticulum membrane contact site | 5.37e-03 | 23 | 100 | 2 | GO:0044233 | |
| HumanPheno | Congenital localized absence of skin | 7.10e-07 | 9 | 46 | 4 | HP:0007383 | |
| HumanPheno | Mitten deformity | 7.10e-07 | 9 | 46 | 4 | HP:0004057 | |
| HumanPheno | Abnormal dermatological laboratory findings | 1.18e-06 | 10 | 46 | 4 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 1.18e-06 | 10 | 46 | 4 | HP:0003341 | |
| HumanPheno | Subepidermal blistering | 1.83e-06 | 11 | 46 | 4 | HP:0033804 | |
| HumanPheno | Blistering by histological location | 3.92e-06 | 13 | 46 | 4 | HP:0033801 | |
| HumanPheno | Oral mucosal blisters | 5.46e-06 | 14 | 46 | 4 | HP:0200097 | |
| HumanPheno | Urethral stricture | 1.27e-05 | 17 | 46 | 4 | HP:0012227 | |
| HumanPheno | Milia | 1.27e-05 | 17 | 46 | 4 | HP:0001056 | |
| HumanPheno | Atrophic scars | 1.69e-05 | 37 | 46 | 5 | HP:0001075 | |
| HumanPheno | Hypoplastic dermoepidermal hemidesmosomes | 2.35e-05 | 7 | 46 | 3 | HP:0020117 | |
| HumanPheno | Aplasia cutis congenita | 2.83e-05 | 41 | 46 | 5 | HP:0001057 | |
| HumanPheno | Atypical scarring of skin | 4.53e-05 | 74 | 46 | 6 | HP:0000987 | |
| HumanPheno | Blistering by anatomical location | 7.53e-05 | 26 | 46 | 4 | HP:0033800 | |
| HumanPheno | Fifth metacarpal with ulnar notch | 7.98e-05 | 2 | 46 | 2 | HP:0005900 | |
| HumanPheno | Recurrent loss of toenails and fingernails | 7.98e-05 | 2 | 46 | 2 | HP:0008390 | |
| HumanPheno | Calvarial skull defect | 1.02e-04 | 28 | 46 | 4 | HP:0001362 | |
| HumanPheno | Skin erosion | 1.02e-04 | 28 | 46 | 4 | HP:0200041 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 1.08e-04 | 11 | 46 | 3 | HP:0032449 | |
| HumanPheno | Abnormal dermoepidermal junction morphology | 1.43e-04 | 12 | 46 | 3 | HP:0031538 | |
| HumanPheno | Abnormal upper to lower segment ratio | 2.38e-04 | 3 | 46 | 2 | HP:0012772 | |
| HumanPheno | Scarring | 2.72e-04 | 102 | 46 | 6 | HP:0100699 | |
| HumanPheno | Anonychia | 2.85e-04 | 66 | 46 | 5 | HP:0001798 | |
| HumanPheno | Limited wrist movement | 2.91e-04 | 15 | 46 | 3 | HP:0006248 | |
| HumanPheno | Enamel hypoplasia | 3.03e-04 | 104 | 46 | 6 | HP:0006297 | |
| HumanPheno | Fragile skin | 3.09e-04 | 37 | 46 | 4 | HP:0001030 | |
| HumanPheno | Dermal atrophy | 3.53e-04 | 107 | 46 | 6 | HP:0004334 | |
| HumanPheno | Aplasia/Hypoplasia of the bladder | 3.56e-04 | 16 | 46 | 3 | HP:0010476 | |
| HumanPheno | Laryngeal stenosis | 3.56e-04 | 16 | 46 | 3 | HP:0001602 | |
| HumanPheno | Scarring alopecia of scalp | 3.56e-04 | 16 | 46 | 3 | HP:0004552 | |
| HumanPheno | Limited wrist extension | 4.73e-04 | 4 | 46 | 2 | HP:0006251 | |
| HumanPheno | Abnormal neural tube morphology | HSPG2 FRAS1 LAMB1 NOTCH2NLC ITGB4 CRB1 DLL3 TNXB NOTCH1 NOTCH3 | 4.91e-04 | 324 | 46 | 10 | HP:0410043 |
| HumanPheno | Neural tube defect | HSPG2 FRAS1 LAMB1 NOTCH2NLC ITGB4 CRB1 DLL3 TNXB NOTCH1 NOTCH3 | 4.91e-04 | 324 | 46 | 10 | HP:0045005 |
| MousePheno | blistering | 3.04e-07 | 24 | 86 | 5 | MP:0001208 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 6.37e-07 | 12 | 86 | 4 | MP:0011159 | |
| MousePheno | abnormal axial skeleton morphology | HSPG2 FAT4 FRAS1 PHF19 MBOAT7 LAMA2 LAMA3 LAMA5 LAMC2 SSPOP VWDE ITGB6 JAG2 FBN1 FBN2 TENM4 TNN DLL3 EHMT1 LRP6 PRMT2 ALAD LTBP3 NOTCH1 NOTCH3 | 1.32e-06 | 1458 | 86 | 25 | MP:0002114 |
| MousePheno | abnormal jaw morphology | HSPG2 FRAS1 LAMA3 LAMA5 LAMC2 VWDE ITGB6 JAG2 FBN1 FBN2 TNN EHMT1 LRP6 LTBP3 | 3.93e-06 | 530 | 86 | 14 | MP:0000454 |
| MousePheno | abnormal basement membrane morphology | 4.35e-06 | 40 | 86 | 5 | MP:0004272 | |
| MousePheno | abnormal cranium morphology | HSPG2 FRAS1 MBOAT7 LAMA2 LAMA3 LAMA5 LAMC2 VWDE ITGB6 JAG2 FBN1 FBN2 TNN DLL3 EHMT1 LRP6 LTBP3 | 7.56e-06 | 813 | 86 | 17 | MP:0000438 |
| MousePheno | abnormal enamel morphology | 7.89e-06 | 45 | 86 | 5 | MP:0002576 | |
| MousePheno | abnormal craniofacial bone morphology | HSPG2 FRAS1 MBOAT7 LAMA2 LAMA3 LAMA5 LAMC2 VWDE ITGB6 JAG2 FBN1 FBN2 TNN DLL3 EHMT1 LRP6 LTBP3 | 9.47e-06 | 827 | 86 | 17 | MP:0002116 |
| MousePheno | abnormal viscerocranium morphology | HSPG2 FRAS1 LAMA3 LAMA5 LAMC2 VWDE ITGB6 JAG2 FBN1 FBN2 TNN EHMT1 LRP6 LTBP3 | 1.41e-05 | 593 | 86 | 14 | MP:0005274 |
| MousePheno | dermal-epidermal separation | 1.84e-05 | 9 | 86 | 3 | MP:0011160 | |
| MousePheno | abnormal vertebral column morphology | HSPG2 FAT4 FRAS1 PHF19 LAMA2 SSPOP JAG2 FBN1 FBN2 TENM4 DLL3 LRP6 PRMT2 LTBP3 NOTCH1 NOTCH3 | 2.07e-05 | 787 | 86 | 16 | MP:0004703 |
| MousePheno | abnormal thoracic cage morphology | HSPG2 FAT4 FRAS1 PHF19 SSPOP FBN1 FBN2 TENM4 DLL3 LRP6 ALAD LTBP3 | 2.50e-05 | 463 | 86 | 12 | MP:0004624 |
| MousePheno | abnormal vertebrae morphology | HSPG2 FAT4 FRAS1 PHF19 JAG2 FBN1 FBN2 TENM4 DLL3 LRP6 PRMT2 LTBP3 NOTCH1 | 2.72e-05 | 546 | 86 | 13 | MP:0000137 |
| MousePheno | abnormal ear morphology | HSPG2 FAT4 IKZF2 LAMA2 LAMA5 LAMC2 MUC5B GRXCR1 JAG2 FBN2 LRP6 NOTCH1 | 2.90e-05 | 470 | 86 | 12 | MP:0002102 |
| MousePheno | abnormal tooth hard tissue morphology | 4.16e-05 | 63 | 86 | 5 | MP:0003930 | |
| MousePheno | abnormal mouth morphology | HSPG2 COL7A1 FRAS1 LAMA3 LAMA5 LAMC2 ITGB4 VWDE ITGB6 JAG2 TNN EHMT1 LRP6 LTBP3 | 5.44e-05 | 670 | 86 | 14 | MP:0000452 |
| MousePheno | abnormal skeleton physiology | NID2 HSPG2 FAT4 LAMA2 PGR FBN1 FBN2 SCUBE2 DLL3 EHMT1 LRP6 LTBP3 NOTCH3 | 1.21e-04 | 632 | 86 | 13 | MP:0001533 |
| MousePheno | abnormal tooth morphology | 1.44e-04 | 318 | 86 | 9 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 1.47e-04 | 319 | 86 | 9 | MP:0030254 | |
| MousePheno | abnormal respiratory mechanics | 1.81e-04 | 135 | 86 | 6 | MP:0002314 | |
| MousePheno | abnormal craniofacial morphology | HSPG2 COL7A1 FRAS1 MBOAT7 LAMA2 LAMA3 LAMA5 LAMC2 ITGB4 VWDE ITGB6 JAG2 FBN1 FBN2 TNN DLL3 EHMT1 LRP6 LTBP3 NOTCH1 | 1.96e-04 | 1372 | 86 | 20 | MP:0000428 |
| MousePheno | craniofacial phenotype | HSPG2 COL7A1 FRAS1 MBOAT7 LAMA2 LAMA3 LAMA5 LAMC2 ITGB4 VWDE ITGB6 JAG2 FBN1 FBN2 TNN DLL3 EHMT1 LRP6 LTBP3 NOTCH1 | 1.96e-04 | 1372 | 86 | 20 | MP:0005382 |
| MousePheno | osteoarthritis | 2.76e-04 | 21 | 86 | 3 | MP:0003560 | |
| MousePheno | abnormal respiration | HSPG2 FRAS1 LAMA2 LAMA3 LAMC2 MUC5B ITGB4 ITGB6 JAG2 FBN1 SLIT3 MUC4 | 2.84e-04 | 598 | 86 | 12 | MP:0001943 |
| MousePheno | abnormal appendicular skeleton morphology | HSPG2 COL7A1 FAT4 FRAS1 SSPOP PGR JAG2 ACSL4 FBN1 FBN2 TENM4 SCUBE2 DLL3 ALAD LTBP3 | 3.37e-04 | 896 | 86 | 15 | MP:0009250 |
| MousePheno | abnormal somatic sensory system morphology | FAT4 LAMA2 LAMB2 GRXCR1 TENM2 CRB1 JAG2 TENM3 DLL3 LRP6 EGFLAM MEGF11 NOTCH1 | 3.39e-04 | 702 | 86 | 13 | MP:0000959 |
| MousePheno | abnormal digit development | 3.64e-04 | 23 | 86 | 3 | MP:0006280 | |
| MousePheno | abnormal interdigital cell death | 3.70e-04 | 5 | 86 | 2 | MP:0009874 | |
| MousePheno | abnormal extracellular matrix morphology | 3.73e-04 | 100 | 86 | 5 | MP:0013258 | |
| MousePheno | curly tail | 4.11e-04 | 57 | 86 | 4 | MP:0003051 | |
| MousePheno | abnormal somatic nervous system morphology | HSPG2 FAT4 LAMA2 LAMB2 GRXCR1 TENM2 CRB1 JAG2 FBN2 HMCN1 TENM3 DLL3 LRP6 EGFLAM MEGF11 NOTCH1 | 4.56e-04 | 1025 | 86 | 16 | MP:0002752 |
| MousePheno | abnormal vertebrae development | 4.70e-04 | 59 | 86 | 4 | MP:0005225 | |
| MousePheno | abnormal pectoral girdle bone morphology | 5.21e-04 | 301 | 86 | 8 | MP:0004508 | |
| MousePheno | abnormal tooth development | 5.31e-04 | 108 | 86 | 5 | MP:0000116 | |
| MousePheno | abnormal basal lamina morphology | 5.52e-04 | 6 | 86 | 2 | MP:0004273 | |
| MousePheno | abnormal autopod morphology | 6.45e-04 | 390 | 86 | 9 | MP:0000572 | |
| MousePheno | abnormal bone ossification | 7.06e-04 | 395 | 86 | 9 | MP:0008271 | |
| MousePheno | abnormal respiratory function | 7.59e-04 | 399 | 86 | 9 | MP:0002327 | |
| MousePheno | increased inflammatory response | NID2 HSPG2 GNE LAMA2 LAMA3 LAMB2 LAMC2 MUC5B ITGB6 PGR MST1 FBN1 LRP6 LTBP3 MST1L NOTCH1 | 7.82e-04 | 1077 | 86 | 16 | MP:0001846 |
| MousePheno | abnormal digit morphology | 8.27e-04 | 323 | 86 | 8 | MP:0002110 | |
| MousePheno | abnormal inflammatory response | NID2 HSPG2 GNE LAMA2 LAMA3 LAMB2 LAMC2 MUC5B ITGB6 IKZF4 PGR MST1 FBN1 LRP6 LTBP3 MST1L MUC4 NOTCH1 | 8.81e-04 | 1310 | 86 | 18 | MP:0001845 |
| MousePheno | abnormal compact bone thickness | 9.24e-04 | 122 | 86 | 5 | MP:0000134 | |
| Domain | EGF_2 | NID2 HSPG2 LAMB4 FAT4 STAB2 NOTCH2NLA LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE NOTCH2NLC SSPOP ITGB4 TENM2 VWDE ITGB6 F12 CRB1 STAB1 JAG2 SNED1 ITGBL1 FBN1 FBN2 PROZ MALRD1 TENM4 SCUBE2 EGF HMCN1 MEGF6 TENM3 MEGF9 SUSD1 ATRAID TNN SLIT3 DLL3 TENM1 LRP6 EGFLAM LTBP3 MUC4 TNXB MEGF11 FBN3 NOTCH1 NOTCH3 CRB2 PEAR1 | 2.28e-72 | 265 | 100 | 53 | PS01186 |
| Domain | EGF | NID2 HSPG2 FAT4 FRAS1 STAB2 NOTCH2NLA LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE NOTCH2NLC TENM2 VWDE F12 CRB1 STAB1 JAG2 SNED1 ITGBL1 FBN1 FBN2 FCGBP PROZ MALRD1 TENM4 SCUBE2 EGF HMCN1 MEGF6 TENM3 MEGF9 SUSD1 ATRAID TNN SLIT3 DLL3 TENM1 LRP6 EGFLAM LTBP3 MUC4 TNXB MEGF11 FBN3 NOTCH1 NOTCH3 CRB2 PEAR1 | 2.29e-71 | 235 | 100 | 51 | SM00181 |
| Domain | EGF_1 | HSPG2 LAMB4 FAT4 STAB2 NOTCH2NLA LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE NOTCH2NLC SSPOP ITGB4 TENM2 VWDE ITGB6 F12 CRB1 STAB1 JAG2 SNED1 ITGBL1 FBN1 FBN2 PROZ MALRD1 TENM4 SCUBE2 EGF HMCN1 MEGF6 TENM3 MEGF9 SUSD1 ATRAID TNN SLIT3 DLL3 TENM1 LRP6 EGFLAM LTBP3 MUC4 TNXB MEGF11 FBN3 NOTCH1 NOTCH3 CRB2 PEAR1 | 2.40e-71 | 255 | 100 | 52 | PS00022 |
| Domain | EGF-like_dom | NID2 HSPG2 FAT4 FRAS1 STAB2 NOTCH2NLA LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE NOTCH2NLC TENM2 VWDE F12 CRB1 STAB1 JAG2 SNED1 ITGBL1 FBN1 FBN2 FCGBP PROZ MALRD1 TENM4 SCUBE2 EGF HMCN1 MEGF6 TENM3 MEGF9 SUSD1 ATRAID TNN SLIT3 DLL3 TENM1 LRP6 EGFLAM LTBP3 MUC4 TNXB MEGF11 FBN3 NOTCH1 NOTCH3 CRB2 PEAR1 | 6.02e-70 | 249 | 100 | 51 | IPR000742 |
| Domain | EGF-like_CS | NID2 HSPG2 LAMB4 FAT4 STAB2 NOTCH2NLA LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE NOTCH2NLC ITGB4 TENM2 VWDE ITGB6 F12 CRB1 STAB1 JAG2 SNED1 FBN1 FBN2 PROZ MALRD1 TENM4 SCUBE2 EGF HMCN1 MEGF6 TENM3 MEGF9 SUSD1 ATRAID TNN SLIT3 DLL3 TENM1 LRP6 EGFLAM LTBP3 MUC4 TNXB MEGF11 FBN3 NOTCH1 NOTCH3 CRB2 PEAR1 | 8.45e-69 | 261 | 100 | 51 | IPR013032 |
| Domain | EGF_3 | NID2 HSPG2 FAT4 STAB2 NOTCH2NLA VWCE NOTCH2NLC SSPOP TENM2 VWDE F12 CRB1 STAB1 JAG2 SNED1 FBN1 FBN2 PROZ MALRD1 TENM4 SCUBE2 EGF HMCN1 MEGF6 TENM3 SUSD1 ATRAID TNN SLIT3 DLL3 TENM1 LRP6 EGFLAM LTBP3 MUC4 TNXB MEGF11 FBN3 NOTCH1 NOTCH3 CRB2 PEAR1 | 5.14e-54 | 235 | 100 | 42 | PS50026 |
| Domain | EGF_CA | NID2 HSPG2 FAT4 STAB2 NOTCH2NLA VWCE NOTCH2NLC TENM2 F12 CRB1 STAB1 JAG2 SNED1 FBN1 FBN2 PROZ SCUBE2 EGF HMCN1 MEGF6 SUSD1 SLIT3 DLL3 EGFLAM LTBP3 FBN3 NOTCH1 NOTCH3 CRB2 | 1.04e-40 | 122 | 100 | 29 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | NID2 HSPG2 FAT4 STAB2 NOTCH2NLA VWCE NOTCH2NLC TENM2 F12 CRB1 STAB1 JAG2 SNED1 FBN1 FBN2 PROZ SCUBE2 EGF HMCN1 MEGF6 SUSD1 SLIT3 DLL3 EGFLAM LTBP3 FBN3 NOTCH1 NOTCH3 CRB2 | 1.76e-40 | 124 | 100 | 29 | IPR001881 |
| Domain | Growth_fac_rcpt_ | NID2 HSPG2 FAT4 FRAS1 STAB2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE CRB1 STAB1 JAG2 FBN1 FBN2 SCUBE2 EGF HMCN1 MEGF6 SUSD1 TNN SLIT3 DLL3 LTBP3 TNXB FBN3 NOTCH1 NOTCH3 | 2.67e-37 | 156 | 100 | 29 | IPR009030 |
| Domain | EGF | NID2 HSPG2 STAB2 NOTCH2NLA NOTCH2NLC F12 CRB1 STAB1 JAG2 SNED1 PROZ MALRD1 SCUBE2 EGF HMCN1 MEGF6 SLIT3 DLL3 LRP6 EGFLAM MUC4 TNXB FBN3 NOTCH1 NOTCH3 CRB2 | 1.09e-34 | 126 | 100 | 26 | PF00008 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NID2 FAT4 NOTCH2NLA VWCE NOTCH2NLC CRB1 JAG2 SNED1 FBN1 FBN2 PROZ SCUBE2 EGF HMCN1 MEGF6 SUSD1 SLIT3 LTBP3 FBN3 NOTCH1 NOTCH3 CRB2 | 1.97e-29 | 106 | 100 | 22 | IPR000152 |
| Domain | EGF_Ca-bd_CS | NID2 FAT4 NOTCH2NLA VWCE NOTCH2NLC CRB1 JAG2 SNED1 FBN1 FBN2 SCUBE2 EGF HMCN1 MEGF6 SUSD1 SLIT3 LTBP3 FBN3 NOTCH1 NOTCH3 CRB2 | 1.55e-28 | 97 | 100 | 21 | IPR018097 |
| Domain | EGF_CA | NID2 FAT4 NOTCH2NLA VWCE NOTCH2NLC CRB1 JAG2 SNED1 FBN1 FBN2 SCUBE2 EGF HMCN1 MEGF6 SUSD1 SLIT3 LTBP3 FBN3 NOTCH1 NOTCH3 CRB2 | 2.49e-28 | 99 | 100 | 21 | PS01187 |
| Domain | ASX_HYDROXYL | NID2 FAT4 NOTCH2NLA VWCE NOTCH2NLC CRB1 JAG2 SNED1 FBN1 FBN2 PROZ SCUBE2 EGF HMCN1 MEGF6 SUSD1 LTBP3 FBN3 NOTCH1 NOTCH3 CRB2 | 3.14e-28 | 100 | 100 | 21 | PS00010 |
| Domain | EGF_Lam | HSPG2 LAMB4 STAB2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 STAB1 MEGF6 MEGF9 MEGF11 PEAR1 | 1.31e-23 | 35 | 100 | 14 | SM00180 |
| Domain | EGF_extracell | STAB2 ITGB4 ITGB6 STAB1 JAG2 ITGBL1 TENM4 MEGF6 TENM3 TNN DLL3 TENM1 TNXB MEGF11 NOTCH1 NOTCH3 | 1.60e-23 | 60 | 100 | 16 | IPR013111 |
| Domain | EGF_2 | STAB2 ITGB4 ITGB6 STAB1 JAG2 ITGBL1 TENM4 MEGF6 TENM3 TNN DLL3 TENM1 TNXB MEGF11 NOTCH1 NOTCH3 | 1.60e-23 | 60 | 100 | 16 | PF07974 |
| Domain | hEGF | FAT4 CRB1 JAG2 SNED1 FBN2 MEGF6 DLL3 LTBP3 MEGF11 FBN3 NOTCH1 NOTCH3 CRB2 | 4.64e-23 | 28 | 100 | 13 | PF12661 |
| Domain | Laminin_EGF | HSPG2 LAMB4 STAB2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 STAB1 MEGF6 MEGF9 MEGF11 PEAR1 | 5.37e-23 | 38 | 100 | 14 | IPR002049 |
| Domain | EGF_CA | NID2 FAT4 NOTCH2NLA VWCE NOTCH2NLC JAG2 FBN1 FBN2 SCUBE2 EGF HMCN1 MEGF6 SUSD1 LTBP3 FBN3 NOTCH1 NOTCH3 | 1.73e-22 | 86 | 100 | 17 | PF07645 |
| Domain | Laminin_EGF | HSPG2 LAMB4 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 STAB1 MEGF6 MEGF9 MEGF11 PEAR1 | 1.77e-21 | 35 | 100 | 13 | PF00053 |
| Domain | EGF_LAM_2 | HSPG2 LAMB4 STAB2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 STAB1 MEGF9 | 2.95e-18 | 30 | 100 | 11 | PS50027 |
| Domain | EGF_LAM_1 | HSPG2 LAMB4 STAB2 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 STAB1 MEGF9 | 2.95e-18 | 30 | 100 | 11 | PS01248 |
| Domain | LAM_G_DOMAIN | 3.59e-13 | 38 | 100 | 9 | PS50025 | |
| Domain | Laminin_G | 5.15e-13 | 58 | 100 | 10 | IPR001791 | |
| Domain | Laminin_G_2 | 5.97e-13 | 40 | 100 | 9 | PF02210 | |
| Domain | LamG | 1.52e-12 | 44 | 100 | 9 | SM00282 | |
| Domain | YD | 3.98e-12 | 5 | 100 | 5 | IPR006530 | |
| Domain | VWC_out | 4.87e-12 | 19 | 100 | 7 | SM00215 | |
| Domain | - | 9.15e-12 | 11 | 100 | 6 | 2.40.155.10 | |
| Domain | GFP-like | 9.15e-12 | 11 | 100 | 6 | IPR023413 | |
| Domain | cEGF | 6.17e-11 | 26 | 100 | 7 | IPR026823 | |
| Domain | cEGF | 6.17e-11 | 26 | 100 | 7 | PF12662 | |
| Domain | - | 8.48e-11 | 95 | 100 | 10 | 2.60.120.200 | |
| Domain | VWD | 1.55e-10 | 16 | 100 | 6 | SM00216 | |
| Domain | VWF_type-D | 1.55e-10 | 16 | 100 | 6 | IPR001846 | |
| Domain | Laminin_N | 1.55e-10 | 16 | 100 | 6 | IPR008211 | |
| Domain | LAMININ_NTER | 1.55e-10 | 16 | 100 | 6 | PS51117 | |
| Domain | VWFD | 1.55e-10 | 16 | 100 | 6 | PS51233 | |
| Domain | Laminin_N | 1.55e-10 | 16 | 100 | 6 | PF00055 | |
| Domain | VWD | 1.55e-10 | 16 | 100 | 6 | PF00094 | |
| Domain | LamNT | 1.55e-10 | 16 | 100 | 6 | SM00136 | |
| Domain | LAMININ_IVA | 2.20e-10 | 8 | 100 | 5 | PS51115 | |
| Domain | Laminin_B | 2.20e-10 | 8 | 100 | 5 | PF00052 | |
| Domain | LamB | 2.20e-10 | 8 | 100 | 5 | SM00281 | |
| Domain | Laminin_IV | 2.20e-10 | 8 | 100 | 5 | IPR000034 | |
| Domain | Tox-GHH_dom | 7.74e-10 | 4 | 100 | 4 | IPR028916 | |
| Domain | Ten_N | 7.74e-10 | 4 | 100 | 4 | IPR009471 | |
| Domain | Ten_N | 7.74e-10 | 4 | 100 | 4 | PF06484 | |
| Domain | TENEURIN_N | 7.74e-10 | 4 | 100 | 4 | PS51361 | |
| Domain | Tox-GHH | 7.74e-10 | 4 | 100 | 4 | PF15636 | |
| Domain | VWC | 1.12e-09 | 38 | 100 | 7 | SM00214 | |
| Domain | - | 1.36e-09 | 39 | 100 | 7 | 2.120.10.30 | |
| Domain | ConA-like_dom | HSPG2 FAT4 COL16A1 LAMA2 LAMA3 LAMA5 ITGB4 CRB1 MALRD1 SLIT3 EGFLAM CRB2 | 2.12e-09 | 219 | 100 | 12 | IPR013320 |
| Domain | VWF_dom | 2.36e-09 | 42 | 100 | 7 | IPR001007 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.60e-09 | 46 | 100 | 7 | IPR011042 | |
| Domain | TB | 2.67e-08 | 7 | 100 | 4 | PF00683 | |
| Domain | VWFC_1 | 3.46e-08 | 36 | 100 | 6 | PS01208 | |
| Domain | VWFC_2 | 4.87e-08 | 38 | 100 | 6 | PS50184 | |
| Domain | - | 5.33e-08 | 8 | 100 | 4 | 3.90.290.10 | |
| Domain | TB | 9.55e-08 | 9 | 100 | 4 | PS51364 | |
| Domain | TB_dom | 9.55e-08 | 9 | 100 | 4 | IPR017878 | |
| Domain | Rhs_assc_core | 1.49e-07 | 3 | 100 | 3 | IPR022385 | |
| Domain | LAMININ_IVB | 1.49e-07 | 3 | 100 | 3 | PS51116 | |
| Domain | Laminin_IV_B | 1.49e-07 | 3 | 100 | 3 | IPR013015 | |
| Domain | FBN | 1.49e-07 | 3 | 100 | 3 | IPR011398 | |
| Domain | EGF_3 | 3.71e-07 | 12 | 100 | 4 | PF12947 | |
| Domain | TIL | 3.71e-07 | 12 | 100 | 4 | PF01826 | |
| Domain | EGF_dom | 3.71e-07 | 12 | 100 | 4 | IPR024731 | |
| Domain | C8 | 3.71e-07 | 12 | 100 | 4 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 5.33e-07 | 13 | 100 | 4 | IPR014853 | |
| Domain | C8 | 5.33e-07 | 13 | 100 | 4 | SM00832 | |
| Domain | NHL | 5.33e-07 | 13 | 100 | 4 | PS51125 | |
| Domain | TIL_dom | 7.43e-07 | 14 | 100 | 4 | IPR002919 | |
| Domain | NIDO_dom | 1.48e-06 | 5 | 100 | 3 | IPR003886 | |
| Domain | Laminin_aI | 1.48e-06 | 5 | 100 | 3 | IPR009254 | |
| Domain | NIDO | 1.48e-06 | 5 | 100 | 3 | SM00539 | |
| Domain | NIDO | 1.48e-06 | 5 | 100 | 3 | PF06119 | |
| Domain | Laminin_I | 1.48e-06 | 5 | 100 | 3 | PF06008 | |
| Domain | Laminin_II | 1.48e-06 | 5 | 100 | 3 | PF06009 | |
| Domain | Laminin_domII | 1.48e-06 | 5 | 100 | 3 | IPR010307 | |
| Domain | NIDO | 1.48e-06 | 5 | 100 | 3 | PS51220 | |
| Domain | EMI | 1.75e-06 | 17 | 100 | 4 | PS51041 | |
| Domain | CTCK_1 | 2.23e-06 | 18 | 100 | 4 | PS01185 | |
| Domain | Cys_knot_C | 8.98e-06 | 25 | 100 | 4 | IPR006207 | |
| Domain | CTCK_2 | 8.98e-06 | 25 | 100 | 4 | PS01225 | |
| Domain | Integrin_bsu | 1.22e-05 | 9 | 100 | 3 | IPR015812 | |
| Domain | INTEGRIN_BETA | 1.22e-05 | 9 | 100 | 3 | PS00243 | |
| Domain | Laminin_G_1 | 2.38e-05 | 11 | 100 | 3 | PF00054 | |
| Domain | fn3 | 2.64e-05 | 162 | 100 | 7 | PF00041 | |
| Domain | Ldl_recept_b | 5.19e-05 | 14 | 100 | 3 | PF00058 | |
| Domain | LDLRB | 5.19e-05 | 14 | 100 | 3 | PS51120 | |
| Domain | LDLR_class-A_CS | 6.10e-05 | 40 | 100 | 4 | IPR023415 | |
| Domain | FN3 | 6.15e-05 | 185 | 100 | 7 | SM00060 | |
| Domain | LY | 6.47e-05 | 15 | 100 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.47e-05 | 15 | 100 | 3 | IPR000033 | |
| Domain | EMI_domain | 7.93e-05 | 16 | 100 | 3 | IPR011489 | |
| Domain | G2F | 8.48e-05 | 3 | 100 | 2 | SM00682 | |
| Domain | DUF3454 | 8.48e-05 | 3 | 100 | 2 | PF11936 | |
| Domain | DUF3454_notch | 8.48e-05 | 3 | 100 | 2 | IPR024600 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.33e-16 | 30 | 74 | 10 | M27216 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NID2 HSPG2 COL7A1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 FBN1 FBN2 TNN LTBP3 TNXB FBN3 | 1.20e-14 | 300 | 74 | 18 | M610 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | HSPG2 LAMB4 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 TNN TNXB | 1.44e-14 | 84 | 74 | 12 | M7098 |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.66e-14 | 11 | 74 | 7 | M158 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.73e-12 | 46 | 74 | 9 | M239 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.97e-10 | 76 | 74 | 9 | M27219 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 3.15e-10 | 33 | 74 | 7 | M39503 | |
| Pathway | KEGG_FOCAL_ADHESION | LAMB4 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 EGF TNN TNXB | 4.58e-10 | 199 | 74 | 12 | M7253 |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.00e-10 | 59 | 74 | 8 | M27218 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.76e-09 | 66 | 74 | 8 | M18 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.82e-09 | 140 | 74 | 10 | M587 | |
| Pathway | WP_FOCAL_ADHESION | LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 EGF TNN TNXB | 3.37e-09 | 187 | 74 | 11 | MM15913 |
| Pathway | WP_FOCAL_ADHESION | LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 EGF TNN TNXB | 6.47e-09 | 199 | 74 | 11 | M39402 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.15e-09 | 30 | 74 | 6 | M27772 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 5.00e-08 | 66 | 74 | 7 | MM15925 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.62e-08 | 41 | 74 | 6 | M27778 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | NID2 COL7A1 COL16A1 ITGB4 ITGB6 FBN1 FBN2 MEGF6 TNN LTBP3 TNXB | 9.41e-08 | 258 | 74 | 11 | MM14572 |
| Pathway | WP_PI3KAKT_SIGNALING | LAMB4 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 EGF TNN TNXB | 1.77e-07 | 339 | 74 | 12 | M39736 |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.70e-07 | 84 | 74 | 7 | M3228 | |
| Pathway | WP_CANCER_PATHWAYS | LAMB4 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 JAG2 MST1 EGF DLL3 LRP6 NOTCH1 NOTCH3 | 3.18e-07 | 507 | 74 | 14 | M48302 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 EGF TNN TNXB | 4.58e-07 | 302 | 74 | 11 | M39719 |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 4.83e-07 | 13 | 74 | 4 | M47423 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 6.75e-07 | 96 | 74 | 7 | M39834 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 EGF TNN TNXB | 9.74e-07 | 326 | 74 | 11 | MM15917 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.33e-06 | 37 | 74 | 5 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.22e-06 | 44 | 74 | 5 | M26969 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.50e-06 | 79 | 74 | 6 | M27643 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.54e-06 | 49 | 74 | 5 | M618 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 8.14e-06 | 25 | 74 | 4 | M27879 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 9.74e-06 | 143 | 74 | 7 | M27275 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.12e-05 | 27 | 74 | 4 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.14e-05 | 9 | 74 | 3 | M47866 | |
| Pathway | PID_NOTCH_PATHWAY | 1.40e-05 | 59 | 74 | 5 | M17 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.58e-05 | 154 | 74 | 7 | M39739 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.73e-05 | 30 | 74 | 4 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.73e-05 | 30 | 74 | 4 | MM15812 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 2.22e-05 | 11 | 74 | 3 | M27372 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.25e-05 | 32 | 74 | 4 | MM14854 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.80e-05 | 68 | 74 | 5 | M27303 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.70e-05 | 72 | 74 | 5 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.95e-05 | 73 | 74 | 5 | MM15906 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 5.01e-05 | 39 | 74 | 4 | MM14604 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.01e-05 | 39 | 74 | 4 | MM14601 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 6.04e-05 | 15 | 74 | 3 | M27161 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.04e-05 | 15 | 74 | 3 | MM14922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 6.04e-05 | 15 | 74 | 3 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 7.40e-05 | 16 | 74 | 3 | M47424 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.22e-05 | 85 | 74 | 5 | M16441 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 8.86e-05 | 45 | 74 | 4 | M39571 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 8.96e-05 | 17 | 74 | 3 | M39389 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 9.35e-05 | 439 | 74 | 10 | M42563 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 9.66e-05 | 46 | 74 | 4 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.05e-04 | 47 | 74 | 4 | M7946 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.08e-04 | 90 | 74 | 5 | M631 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.27e-04 | 19 | 74 | 3 | MM15594 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.73e-04 | 21 | 74 | 3 | MM15706 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 2.56e-04 | 59 | 74 | 4 | M39886 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.69e-04 | 5 | 74 | 2 | M27411 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 2.69e-04 | 5 | 74 | 2 | MM15874 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.69e-04 | 5 | 74 | 2 | MM14733 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.91e-04 | 61 | 74 | 4 | M39540 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.91e-04 | 61 | 74 | 4 | M27103 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.94e-04 | 25 | 74 | 3 | M39713 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 2.94e-04 | 325 | 74 | 8 | M12868 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.32e-04 | 250 | 74 | 7 | M27554 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.84e-04 | 118 | 74 | 5 | M39852 | |
| Pathway | REACTOME_SIGNALING_BY_MST1 | 4.02e-04 | 6 | 74 | 2 | MM15492 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 4.02e-04 | 6 | 74 | 2 | M27068 | |
| Pathway | BIOCARTA_MSP_PATHWAY | 5.61e-04 | 7 | 74 | 2 | MM1580 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 5.61e-04 | 7 | 74 | 2 | M27199 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 5.61e-04 | 7 | 74 | 2 | M47805 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 5.61e-04 | 7 | 74 | 2 | MM14734 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 5.62e-04 | 31 | 74 | 3 | M592 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.75e-04 | 76 | 74 | 4 | MM14867 | |
| Pathway | WP_MIR302367_PROMOTING_CARDIOMYOCYTE_PROLIFERATION | 7.46e-04 | 8 | 74 | 2 | MM15986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 7.46e-04 | 8 | 74 | 2 | M47850 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 8.98e-04 | 82 | 74 | 4 | MM15922 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 9.56e-04 | 9 | 74 | 2 | MM15117 | |
| Pathway | WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS | 9.56e-04 | 9 | 74 | 2 | M39869 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.03e-03 | 38 | 74 | 3 | MM14874 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 1.19e-03 | 10 | 74 | 2 | MM14849 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.45e-03 | 11 | 74 | 2 | M48021 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 1.45e-03 | 11 | 74 | 2 | M27317 | |
| Pathway | REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION | 1.45e-03 | 11 | 74 | 2 | MM15035 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.45e-03 | 11 | 74 | 2 | M47865 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS | 1.45e-03 | 11 | 74 | 2 | M47626 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.47e-03 | 43 | 74 | 3 | M39565 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.56e-03 | 161 | 74 | 5 | M39770 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.73e-03 | 12 | 74 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.73e-03 | 12 | 74 | 2 | M47533 | |
| Pathway | PID_PS1_PATHWAY | 1.79e-03 | 46 | 74 | 3 | M70 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.79e-03 | 46 | 74 | 3 | M198 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.81e-03 | 532 | 74 | 9 | M27870 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.83e-03 | 246 | 74 | 6 | M10189 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.91e-03 | 47 | 74 | 3 | M646 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.91e-03 | 47 | 74 | 3 | MM14925 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 1.91e-03 | 47 | 74 | 3 | M39829 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4 | 2.04e-03 | 13 | 74 | 2 | M39582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.04e-03 | 13 | 74 | 2 | M47534 | |
| Pathway | WP_OMEGA9_FATTY_ACID_SYNTHESIS | 2.37e-03 | 14 | 74 | 2 | M39780 | |
| Pubmed | NID2 HSPG2 COL7A1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 SSPOP FBN1 FBN2 HMCN1 MEGF6 MUC4 TNXB | 9.26e-20 | 175 | 101 | 16 | 28071719 | |
| Pubmed | 5.16e-19 | 29 | 101 | 10 | 22613833 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.41e-17 | 15 | 101 | 8 | 15895400 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | NID2 HSPG2 COL7A1 FRAS1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 EGFLAM | 5.43e-16 | 79 | 101 | 11 | 18757743 |
| Pubmed | HSPG2 COL7A1 COL16A1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC2 F12 MST1 FBN1 MUC2 TNXB | 8.05e-16 | 153 | 101 | 13 | 25037231 | |
| Pubmed | HSPG2 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 FBN1 HMCN1 MUC2 | 2.54e-15 | 167 | 101 | 13 | 22159717 | |
| Pubmed | 3.59e-15 | 64 | 101 | 10 | 22261194 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | NID2 HSPG2 COL7A1 COL16A1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC2 FBN1 FBN2 TNXB | 6.31e-15 | 135 | 101 | 12 | 28675934 |
| Pubmed | 4.37e-14 | 18 | 101 | 7 | 11311202 | ||
| Pubmed | 1.07e-13 | 10 | 101 | 6 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 2.36e-13 | 11 | 101 | 6 | 21524702 | |
| Pubmed | 4.70e-13 | 12 | 101 | 6 | 9396756 | ||
| Pubmed | NID2 HSPG2 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 FBN1 LTBP3 TNXB | 5.60e-13 | 146 | 101 | 11 | 27068509 | |
| Pubmed | 2.03e-12 | 118 | 101 | 10 | 21078624 | ||
| Pubmed | 4.04e-12 | 16 | 101 | 6 | 17601529 | ||
| Pubmed | 1.04e-11 | 8 | 101 | 5 | 8872465 | ||
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 1.04e-11 | 8 | 101 | 5 | 23529140 | |
| Pubmed | 1.93e-11 | 20 | 101 | 6 | 22911573 | ||
| Pubmed | 2.70e-11 | 21 | 101 | 6 | 27856617 | ||
| Pubmed | 4.65e-11 | 10 | 101 | 5 | 38713721 | ||
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 6.70e-11 | 4 | 101 | 4 | 10225957 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 6.70e-11 | 4 | 101 | 4 | 12000766 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 8.51e-11 | 11 | 101 | 5 | 23472759 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | MBOAT7 NOTCH2NLA LAMA5 LAMB2 VWCE STAB1 JAG2 ITGBL1 FBN1 MEGF6 PRMT2 LTBP3 MEGF11 NOTCH1 NOTCH3 | 8.78e-11 | 560 | 101 | 15 | 21653829 |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.13e-10 | 26 | 101 | 6 | 34189436 | |
| Pubmed | 1.13e-10 | 26 | 101 | 6 | 24742657 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.45e-10 | 97 | 101 | 8 | 27559042 | |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 5.48e-10 | 15 | 101 | 5 | 12921739 | |
| Pubmed | 5.48e-10 | 15 | 101 | 5 | 9264260 | ||
| Pubmed | A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. | 1.00e-09 | 6 | 101 | 4 | 18817539 | |
| Pubmed | 1.00e-09 | 6 | 101 | 4 | 10671376 | ||
| Pubmed | 1.55e-09 | 18 | 101 | 5 | 14730302 | ||
| Pubmed | 1.61e-09 | 71 | 101 | 7 | 33541421 | ||
| Pubmed | 1.83e-09 | 40 | 101 | 6 | 27068110 | ||
| Pubmed | 2.14e-09 | 41 | 101 | 6 | 22675208 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 2.33e-09 | 7 | 101 | 4 | 9004048 | |
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 7921537 | ||
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 14557481 | ||
| Pubmed | 2.33e-09 | 7 | 101 | 4 | 12915301 | ||
| Pubmed | 4.11e-09 | 81 | 101 | 7 | 39217171 | ||
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 4.65e-09 | 8 | 101 | 4 | 9489770 | |
| Pubmed | 4.65e-09 | 8 | 101 | 4 | 10331952 | ||
| Pubmed | 6.03e-09 | 23 | 101 | 5 | 24337118 | ||
| Pubmed | 7.39e-09 | 50 | 101 | 6 | 23658023 | ||
| Pubmed | 8.35e-09 | 9 | 101 | 4 | 11118901 | ||
| Pubmed | 8.35e-09 | 9 | 101 | 4 | 16245338 | ||
| Pubmed | 1.16e-08 | 210 | 101 | 9 | 16537572 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.39e-08 | 10 | 101 | 4 | 23665443 | |
| Pubmed | 1.39e-08 | 10 | 101 | 4 | 11784026 | ||
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 2.18e-08 | 11 | 101 | 4 | 8707838 | |
| Pubmed | 2.18e-08 | 11 | 101 | 4 | 10878608 | ||
| Pubmed | Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. | 2.38e-08 | 3 | 101 | 3 | 15316072 | |
| Pubmed | 2.38e-08 | 3 | 101 | 3 | 17426950 | ||
| Pubmed | 2.87e-08 | 164 | 101 | 8 | 32409323 | ||
| Pubmed | 2.99e-08 | 31 | 101 | 5 | 22274697 | ||
| Pubmed | 3.26e-08 | 12 | 101 | 4 | 26794322 | ||
| Pubmed | 3.26e-08 | 12 | 101 | 4 | 15465494 | ||
| Pubmed | 3.26e-08 | 12 | 101 | 4 | 16750824 | ||
| Pubmed | 4.69e-08 | 13 | 101 | 4 | 36350252 | ||
| Pubmed | 4.69e-08 | 13 | 101 | 4 | 12682087 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 4.69e-08 | 13 | 101 | 4 | 11578869 | |
| Pubmed | 4.69e-08 | 13 | 101 | 4 | 9670011 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.87e-08 | 248 | 101 | 9 | 24006456 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 COL7A1 FAT4 FRAS1 MBOAT7 LAMA5 LAMB1 LAMB2 ITGB4 JAG2 FBN1 FBN2 TENM3 LRP6 LTBP3 NOTCH1 NOTCH3 | 6.55e-08 | 1201 | 101 | 17 | 35696571 |
| Pubmed | 6.56e-08 | 14 | 101 | 4 | 14757642 | ||
| Pubmed | 6.60e-08 | 257 | 101 | 9 | 16335952 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | NID2 HSPG2 FAT4 LAMA3 LAMA5 LAMB2 MUC5B F12 FCGBP PROZ EGF HMCN1 ALAD MUC4 TNXB CRB2 | 7.95e-08 | 1070 | 101 | 16 | 23533145 |
| Pubmed | 8.92e-08 | 15 | 101 | 4 | 12971992 | ||
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 8.92e-08 | 15 | 101 | 4 | 16914494 | |
| Pubmed | Notch signalling pathway mediates hair cell development in mammalian cochlea. | 9.49e-08 | 4 | 101 | 3 | 10080181 | |
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 9.49e-08 | 4 | 101 | 3 | 25034023 | |
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 22691042 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 10801807 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 8081888 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 2099832 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 10651091 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 20819128 | ||
| Pubmed | 9.49e-08 | 4 | 101 | 3 | 22673183 | ||
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 9.49e-08 | 4 | 101 | 3 | 35008625 | |
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 9.49e-08 | 4 | 101 | 3 | 20040020 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.19e-07 | 16 | 101 | 4 | 12617809 | |
| Pubmed | 1.55e-07 | 17 | 101 | 4 | 18694942 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 1.55e-07 | 17 | 101 | 4 | 15056720 | |
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.55e-07 | 17 | 101 | 4 | 15821257 | |
| Pubmed | The notch pathway positively regulates programmed cell death during erythroid differentiation. | 1.86e-07 | 44 | 101 | 5 | 17476283 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.99e-07 | 18 | 101 | 4 | 39040056 | |
| Pubmed | 1.99e-07 | 18 | 101 | 4 | 15689374 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.01e-07 | 86 | 101 | 6 | 28327460 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 11969289 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 2.37e-07 | 5 | 101 | 3 | 11062147 | |
| Pubmed | IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. | 2.37e-07 | 5 | 101 | 3 | 9271670 | |
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 2.37e-07 | 5 | 101 | 3 | 9415429 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 12175503 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 2.37e-07 | 5 | 101 | 3 | 23493297 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 2.37e-07 | 5 | 101 | 3 | 9389447 | |
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 2.37e-07 | 5 | 101 | 3 | 11006133 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 10964500 | ||
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 9719032 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 2.37e-07 | 5 | 101 | 3 | 15064243 | |
| Pubmed | 2.37e-07 | 5 | 101 | 3 | 12743034 | ||
| Interaction | IGFL3 interactions | 3.62e-12 | 75 | 100 | 10 | int:IGFL3 | |
| Interaction | NTN5 interactions | 1.93e-11 | 24 | 100 | 7 | int:NTN5 | |
| Interaction | FBXO2 interactions | NID2 HSPG2 FRAS1 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 JAG2 SNED1 FBN1 FBN2 TENM3 SUSD1 NOTCH1 NOTCH3 | 1.89e-10 | 411 | 100 | 16 | int:FBXO2 |
| Interaction | SIRPD interactions | 4.24e-10 | 86 | 100 | 9 | int:SIRPD | |
| Interaction | HOXA1 interactions | GNE CNFN NOTCH2NLA LAMA5 LAMB2 VWCE ITGB4 JAG2 FBN1 MEGF6 UNKL LTBP3 NOTCH1 NOTCH3 | 2.50e-09 | 356 | 100 | 14 | int:HOXA1 |
| Interaction | MFAP5 interactions | 6.67e-09 | 52 | 100 | 7 | int:MFAP5 | |
| Interaction | NID2 interactions | 1.07e-08 | 86 | 100 | 8 | int:NID2 | |
| Interaction | PRG2 interactions | HSPG2 FRAS1 LAMA5 LAMB2 LAMC2 VWDE JAG2 FBN2 LRP6 LTBP3 NOTCH1 NOTCH3 | 1.76e-08 | 285 | 100 | 12 | int:PRG2 |
| Interaction | LAMA5 interactions | 1.21e-07 | 117 | 100 | 8 | int:LAMA5 | |
| Interaction | CACNA1A interactions | 1.78e-07 | 123 | 100 | 8 | int:CACNA1A | |
| Interaction | CFC1 interactions | 2.15e-07 | 126 | 100 | 8 | int:CFC1 | |
| Interaction | WDR25 interactions | 4.21e-07 | 58 | 100 | 6 | int:WDR25 | |
| Interaction | DEFA1 interactions | 6.57e-07 | 100 | 100 | 7 | int:DEFA1 | |
| Interaction | ZNF74 interactions | 6.75e-07 | 34 | 100 | 5 | int:ZNF74 | |
| Interaction | EDN3 interactions | 1.11e-06 | 108 | 100 | 7 | int:EDN3 | |
| Interaction | KLKB1 interactions | 1.29e-06 | 17 | 100 | 4 | int:KLKB1 | |
| Interaction | LYPD6B interactions | 1.37e-06 | 39 | 100 | 5 | int:LYPD6B | |
| Interaction | PSG8 interactions | 1.77e-06 | 41 | 100 | 5 | int:PSG8 | |
| Interaction | MBD1 interactions | 2.29e-06 | 77 | 100 | 6 | int:MBD1 | |
| Interaction | EGFL7 interactions | 2.29e-06 | 77 | 100 | 6 | int:EGFL7 | |
| Interaction | DEFB125 interactions | 2.60e-06 | 20 | 100 | 4 | int:DEFB125 | |
| Interaction | ZDHHC15 interactions | 2.96e-06 | 125 | 100 | 7 | int:ZDHHC15 | |
| Interaction | CMA1 interactions | 3.17e-06 | 46 | 100 | 5 | int:CMA1 | |
| Interaction | TAFA2 interactions | 3.54e-06 | 47 | 100 | 5 | int:TAFA2 | |
| Interaction | GFI1B interactions | 5.18e-06 | 136 | 100 | 7 | int:GFI1B | |
| Interaction | FBN1 interactions | 5.33e-06 | 51 | 100 | 5 | int:FBN1 | |
| Interaction | LGALS1 interactions | 6.00e-06 | 332 | 100 | 10 | int:LGALS1 | |
| Interaction | SHANK3 interactions | GPM6B MBOAT7 NOTCH2NLA JAG2 ITGBL1 MEGF6 PRMT2 ZFHX3 LTBP3 MEGF11 NOTCH1 NOTCH3 | 6.38e-06 | 496 | 100 | 12 | int:SHANK3 |
| Interaction | ZNF408 interactions | 7.91e-06 | 145 | 100 | 7 | int:ZNF408 | |
| Interaction | GML interactions | 1.01e-05 | 58 | 100 | 5 | int:GML | |
| Interaction | LYPD1 interactions | 1.01e-05 | 58 | 100 | 5 | int:LYPD1 | |
| Interaction | ELN interactions | 1.23e-05 | 29 | 100 | 4 | int:ELN | |
| Interaction | LAMC2 interactions | 1.42e-05 | 30 | 100 | 4 | int:LAMC2 | |
| Interaction | OIT3 interactions | 1.77e-05 | 65 | 100 | 5 | int:OIT3 | |
| Interaction | FBLN2 interactions | 1.91e-05 | 66 | 100 | 5 | int:FBLN2 | |
| Interaction | MFAP2 interactions | 2.52e-05 | 12 | 100 | 3 | int:MFAP2 | |
| Interaction | BAGE2 interactions | 2.55e-05 | 70 | 100 | 5 | int:BAGE2 | |
| Interaction | CEACAM8 interactions | 2.83e-05 | 119 | 100 | 6 | int:CEACAM8 | |
| Interaction | PTPRK interactions | 2.88e-05 | 177 | 100 | 7 | int:PTPRK | |
| Interaction | LLCFC1 interactions | 3.11e-05 | 121 | 100 | 6 | int:LLCFC1 | |
| Interaction | SDF2L1 interactions | 3.23e-05 | 322 | 100 | 9 | int:SDF2L1 | |
| Interaction | IL5RA interactions | 3.57e-05 | 124 | 100 | 6 | int:IL5RA | |
| Interaction | VEGFD interactions | 3.70e-05 | 38 | 100 | 4 | int:VEGFD | |
| Interaction | CST9L interactions | 4.31e-05 | 78 | 100 | 5 | int:CST9L | |
| Interaction | PI15 interactions | 5.81e-05 | 83 | 100 | 5 | int:PI15 | |
| Interaction | TAFA5 interactions | 9.16e-05 | 18 | 100 | 3 | int:TAFA5 | |
| Interaction | LTBP1 interactions | 9.50e-05 | 92 | 100 | 5 | int:LTBP1 | |
| Interaction | CCL19 interactions | 1.08e-04 | 19 | 100 | 3 | int:CCL19 | |
| Interaction | CCN6 interactions | 1.08e-04 | 19 | 100 | 3 | int:CCN6 | |
| Interaction | MAML3 interactions | 1.27e-04 | 20 | 100 | 3 | int:MAML3 | |
| Interaction | TRGV3 interactions | 1.60e-04 | 55 | 100 | 4 | int:TRGV3 | |
| Interaction | ADAM30 interactions | 1.72e-04 | 56 | 100 | 4 | int:ADAM30 | |
| Interaction | ZFP41 interactions | 1.84e-04 | 57 | 100 | 4 | int:ZFP41 | |
| Interaction | INSL5 interactions | 1.97e-04 | 58 | 100 | 4 | int:INSL5 | |
| Interaction | ATXN7 interactions | 2.11e-04 | 109 | 100 | 5 | int:ATXN7 | |
| Interaction | FBXO6 interactions | HSPG2 FRAS1 LAMA3 LAMA5 LAMB1 LAMB2 MUC5B VWDE FBN2 TENM4 SUSD1 LTBP3 | 2.25e-04 | 717 | 100 | 12 | int:FBXO6 |
| Interaction | MANEA interactions | 2.25e-04 | 60 | 100 | 4 | int:MANEA | |
| Interaction | COL7A1 interactions | 2.52e-04 | 25 | 100 | 3 | int:COL7A1 | |
| Interaction | IKZF2 interactions | 2.84e-04 | 26 | 100 | 3 | int:IKZF2 | |
| Interaction | CXCL5 interactions | 3.18e-04 | 27 | 100 | 3 | int:CXCL5 | |
| Interaction | LAMA1 interactions | 3.25e-04 | 66 | 100 | 4 | int:LAMA1 | |
| Interaction | LAMB2 interactions | 3.56e-04 | 122 | 100 | 5 | int:LAMB2 | |
| Interaction | CDHR4 interactions | 3.64e-04 | 68 | 100 | 4 | int:CDHR4 | |
| Interaction | LYPD4 interactions | 3.70e-04 | 123 | 100 | 5 | int:LYPD4 | |
| Interaction | ITGB4 interactions | 3.98e-04 | 125 | 100 | 5 | int:ITGB4 | |
| Interaction | EPHA7 interactions | 5.15e-04 | 282 | 100 | 7 | int:EPHA7 | |
| Interaction | GPIHBP1 interactions | 5.29e-04 | 133 | 100 | 5 | int:GPIHBP1 | |
| Interaction | PLSCR4 interactions | 5.30e-04 | 75 | 100 | 4 | int:PLSCR4 | |
| Interaction | LILRA5 interactions | 5.30e-04 | 32 | 100 | 3 | int:LILRA5 | |
| Interaction | MSTN interactions | 5.80e-04 | 33 | 100 | 3 | int:MSTN | |
| Interaction | ST14 interactions | 5.84e-04 | 207 | 100 | 6 | int:ST14 | |
| Interaction | TAFAZZIN interactions | 5.84e-04 | 207 | 100 | 6 | int:TAFAZZIN | |
| Interaction | VEGFB interactions | 6.34e-04 | 34 | 100 | 3 | int:VEGFB | |
| Interaction | WDR76 interactions | 6.43e-04 | 383 | 100 | 8 | int:WDR76 | |
| Interaction | BCAN interactions | 7.52e-04 | 36 | 100 | 3 | int:BCAN | |
| Interaction | SLURP1 interactions | 7.59e-04 | 144 | 100 | 5 | int:SLURP1 | |
| Interaction | OS9 interactions | 7.84e-04 | 219 | 100 | 6 | int:OS9 | |
| Interaction | GAGE8 interactions | 8.58e-04 | 9 | 100 | 2 | int:GAGE8 | |
| Interaction | IL12RB1 interactions | 9.27e-04 | 87 | 100 | 4 | int:IL12RB1 | |
| Interaction | KLK15 interactions | 9.39e-04 | 151 | 100 | 5 | int:KLK15 | |
| GeneFamily | Laminin subunits | 2.72e-15 | 12 | 61 | 7 | 626 | |
| GeneFamily | Fibronectin type III domain containing | 1.09e-06 | 160 | 61 | 7 | 555 | |
| GeneFamily | CD molecules|Integrin beta subunits | 3.03e-06 | 9 | 61 | 3 | 1159 | |
| GeneFamily | CD molecules|Mucins | 4.65e-05 | 21 | 61 | 3 | 648 | |
| GeneFamily | Ankyrin repeat domain containing | 1.62e-04 | 242 | 61 | 6 | 403 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 3.97e-04 | 9 | 61 | 2 | 1223 | |
| GeneFamily | Fibrinogen C domain containing | 3.20e-03 | 25 | 61 | 2 | 554 | |
| GeneFamily | Acyl-CoA synthetase family | 3.45e-03 | 26 | 61 | 2 | 40 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 3.72e-03 | 27 | 61 | 2 | 1253 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.86e-03 | 34 | 61 | 2 | 487 | |
| GeneFamily | Collagens | 1.05e-02 | 46 | 61 | 2 | 490 | |
| GeneFamily | Nuclear hormone receptors | 1.19e-02 | 49 | 61 | 2 | 71 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.59e-02 | 57 | 61 | 2 | 1179 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.71e-02 | 161 | 61 | 3 | 593 | |
| Coexpression | NABA_CORE_MATRISOME | NID2 HSPG2 LAMB4 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE SSPOP VWDE SNED1 FBN1 FBN2 HMCN1 TNN SLIT3 EGFLAM LTBP3 TNXB FBN3 | 1.32e-27 | 275 | 100 | 25 | M5884 |
| Coexpression | NABA_MATRISOME | NID2 HSPG2 LAMB4 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 MUC5B VWCE SSPOP VWDE F12 MST1 SNED1 SEMA3D FBN1 FBN2 SCUBE2 EGF HMCN1 MEGF6 MEGF9 TNN SLIT3 EGFLAM LTBP3 MST1L MUC2 MUC4 TNXB MEGF11 FBN3 | 1.45e-26 | 1026 | 100 | 37 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 LAMB4 FRAS1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE SSPOP VWDE SNED1 FBN1 FBN2 HMCN1 TNN SLIT3 EGFLAM LTBP3 TNXB FBN3 | 2.21e-26 | 196 | 100 | 22 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | NID2 HSPG2 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE SSPOP VWDE SNED1 FBN1 FBN2 HMCN1 OTOGL TNN SLIT3 EGFLAM LTBP3 TNXB | 2.88e-26 | 270 | 100 | 24 | MM17057 |
| Coexpression | NABA_MATRISOME | NID2 HSPG2 COL7A1 FRAS1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 MUC5B VWCE SSPOP VWDE F12 MST1 SNED1 SEMA3D FBN1 FBN2 SCUBE2 EGF HMCN1 MEGF6 MEGF9 OTOGL TNN SLIT3 EGFLAM LTBP3 MST1L MUC2 MUC4 TNXB MEGF11 | 1.17e-25 | 1008 | 100 | 36 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | NID2 FRAS1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 VWCE SSPOP VWDE SNED1 FBN1 FBN2 HMCN1 OTOGL TNN SLIT3 EGFLAM LTBP3 TNXB | 5.22e-25 | 191 | 100 | 21 | MM17059 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.17e-16 | 40 | 100 | 10 | M5887 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.22e-12 | 23 | 100 | 7 | M48001 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | GPM6B NID2 HSPG2 COL7A1 COL16A1 LAMB2 TENM2 ITGB6 ITGBL1 FBN1 TENM4 OTOGL SLIT3 EGFLAM ADGRL2 TM4SF1 NOTCH3 | 4.89e-09 | 767 | 100 | 17 | M39209 |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.08e-08 | 20 | 100 | 5 | MM17053 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | CACNA1E TNFRSF25 COL7A1 STAB2 OBSCN LAMA2 LAMB1 ITGB4 F12 CRB1 JAG2 MST1 MEGF6 NR0B1 MUC4 TNXB NOTCH3 | 5.84e-08 | 909 | 100 | 17 | M41018 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 7.65e-08 | 200 | 100 | 9 | M5930 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.50e-07 | 16 | 100 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.50e-07 | 16 | 100 | 4 | M2207 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | GPM6B HSPG2 COL7A1 COL16A1 LAMB1 LAMB2 ITGB6 PGR FBN1 FCGBP SCUBE2 MUC4 | 4.03e-07 | 493 | 100 | 12 | M19391 |
| Coexpression | DESCARTES_ORGANOGENESIS_EPITHELIAL_CELLS | 4.98e-06 | 175 | 100 | 7 | MM3643 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 7.33e-06 | 261 | 100 | 8 | M1834 | |
| Coexpression | ATF2_S_UP.V1_DN | 7.69e-06 | 187 | 100 | 7 | M2681 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 8.89e-06 | 268 | 100 | 8 | M45796 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 1.16e-05 | 77 | 100 | 5 | M40001 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.34e-05 | 135 | 100 | 6 | M5825 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 1.53e-05 | 380 | 100 | 9 | M45714 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | HSPG2 FRAS1 LAMA3 LAMA5 LAMC2 MIB2 TENM2 MST1 MEGF6 EGFLAM TM4SF1 TNXB FBN3 CRB2 | 1.59e-05 | 955 | 100 | 14 | M45680 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1E LAMA3 LAMA5 LAMC2 VWCE SSPOP TENM2 IKZF4 JAG2 ACSL4 MEGF6 MEGF9 TENM1 ZFHX3 MUC2 | 1.91e-05 | 1106 | 100 | 15 | M39071 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL | 2.05e-05 | 301 | 100 | 8 | M45708 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 2.34e-05 | 149 | 100 | 6 | M45703 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | OBSCN LAMA5 LAMB2 ACSL4 SNED1 FBN1 SCUBE2 EGFLAM NOTCH3 PEAR1 | 2.37e-05 | 505 | 100 | 10 | M39167 |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 2.37e-05 | 15 | 100 | 3 | MM402 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MUC5B F12 MST1 SEMA3D SCUBE2 EGF MEGF6 MEGF9 MST1L MUC2 MUC4 MEGF11 | 2.48e-05 | 738 | 100 | 12 | MM17058 |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 2.72e-05 | 313 | 100 | 8 | M40228 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | MUC5B F12 MST1 SEMA3D SCUBE2 EGF MEGF6 MEGF9 MST1L MUC2 MUC4 MEGF11 | 2.94e-05 | 751 | 100 | 12 | M5885 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 3.52e-05 | 17 | 100 | 3 | M47995 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_DN | 3.64e-05 | 238 | 100 | 7 | M12004 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 4.82e-05 | 440 | 100 | 9 | M39039 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | NID2 FAT4 LAMB1 LAMC2 SNED1 TENM4 SCUBE2 SLCO4C1 HMCN1 DLL3 EGFLAM MEGF11 NOTCH1 PEAR1 | 5.72e-05 | 1074 | 100 | 14 | M1941 |
| Coexpression | JAEGER_METASTASIS_DN | 6.36e-05 | 260 | 100 | 7 | M10702 | |
| Coexpression | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A | 6.82e-05 | 21 | 100 | 3 | M1501 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 9.67e-05 | 482 | 100 | 9 | M12144 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 1.10e-04 | 284 | 100 | 7 | M16975 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 1.15e-04 | 286 | 100 | 7 | M45746 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.16e-04 | 385 | 100 | 8 | M39264 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 1.17e-04 | 25 | 100 | 3 | M47986 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP | 1.17e-04 | 199 | 100 | 6 | M3641 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 1.20e-04 | 200 | 100 | 6 | M7256 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_UP | 1.31e-04 | 26 | 100 | 3 | M4717 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 1.41e-04 | 206 | 100 | 6 | M14134 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 1.43e-04 | 130 | 100 | 5 | M17428 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.47e-04 | 27 | 100 | 3 | M47994 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 1.49e-04 | 208 | 100 | 6 | M39139 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SURVIVAL_UP | 1.77e-04 | 73 | 100 | 4 | M6939 | |
| Coexpression | PEREZ_TP53_TARGETS | LAMB4 OBSCN MIB2 VWCE JAG2 MST1 MEGF6 UNKL EGFLAM LTBP3 ASB2 MUC2 MEGF11 PEAR1 | 1.85e-04 | 1201 | 100 | 14 | M4391 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 2.14e-04 | 6 | 100 | 2 | M48000 | |
| Coexpression | FRASOR_RESPONSE_TO_ESTRADIOL_DN | 2.29e-04 | 78 | 100 | 4 | M3002 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | NID2 COL16A1 NOTCH2NLA LAMA2 LAMB1 ACSL4 FBN1 HMCN1 NOTCH1 NOTCH3 | 2.78e-04 | 681 | 100 | 10 | M39175 |
| Coexpression | PETRETTO_CARDIAC_HYPERTROPHY | 2.96e-04 | 34 | 100 | 3 | M14043 | |
| Coexpression | MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL | 3.06e-04 | 153 | 100 | 5 | M39171 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 3.07e-04 | 563 | 100 | 9 | M15103 | |
| Coexpression | MULLIGHAN_MLL_SIGNATURE_1_DN | 3.08e-04 | 238 | 100 | 6 | M18841 | |
| Coexpression | AIZARANI_LIVER_C30_HEPATOCYTES_4 | 3.13e-04 | 446 | 100 | 8 | M39129 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_A_UP | 3.19e-04 | 85 | 100 | 4 | M7517 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL | 3.19e-04 | 85 | 100 | 4 | M45761 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.20e-04 | 338 | 100 | 7 | MM17064 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.23e-04 | 35 | 100 | 3 | MM17054 | |
| Coexpression | NABA_SECRETED_FACTORS | 3.49e-04 | 343 | 100 | 7 | M5883 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 3.61e-04 | 704 | 100 | 10 | M45672 | |
| Coexpression | SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER | 3.64e-04 | 88 | 100 | 4 | M11288 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 3.98e-04 | 162 | 100 | 5 | M45037 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 4.08e-04 | 352 | 100 | 7 | M17471 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 4.09e-04 | 163 | 100 | 5 | M2769 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 4.45e-04 | 166 | 100 | 5 | M39026 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | 4.63e-04 | 473 | 100 | 8 | M4306 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 4.63e-04 | 257 | 100 | 6 | M13867 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 5.03e-04 | 479 | 100 | 8 | M2573 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 5.06e-04 | 365 | 100 | 7 | M39018 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 5.10e-04 | 9 | 100 | 2 | M9630 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 5.31e-04 | 483 | 100 | 8 | MM1082 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 5.51e-04 | 174 | 100 | 5 | M45676 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | GPM6B CACNA1E NID2 NOTCH2NLA LAMA3 PGR FBN1 FBN2 NR0B1 ZFHX3 EGFLAM MEGF11 | 5.79e-04 | 1035 | 100 | 12 | M9898 |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 6.26e-04 | 179 | 100 | 5 | M39308 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 6.60e-04 | 103 | 100 | 4 | M1170 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP | 6.83e-04 | 384 | 100 | 7 | M798 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 7.01e-04 | 504 | 100 | 8 | M2157 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 7.75e-04 | 11 | 100 | 2 | M566 | |
| Coexpression | GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN | 8.19e-04 | 190 | 100 | 5 | M4662 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP | 8.19e-04 | 190 | 100 | 5 | M9871 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 8.74e-04 | 111 | 100 | 4 | MM1111 | |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN | 8.99e-04 | 194 | 100 | 5 | M8285 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP | 9.20e-04 | 195 | 100 | 5 | M8006 | |
| Coexpression | LTE2_UP.V1_DN | 9.20e-04 | 195 | 100 | 5 | M2721 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 9.28e-04 | 12 | 100 | 2 | M47983 | |
| Coexpression | CLAUS_PGR_POSITIVE_MENINGIOMA_DN | 9.28e-04 | 12 | 100 | 2 | M14787 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR | 9.34e-04 | 113 | 100 | 4 | M39153 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 9.42e-04 | 196 | 100 | 5 | M9867 | |
| Coexpression | TRAVAGLINI_LUNG_PERICYTE_CELL | 9.65e-04 | 114 | 100 | 4 | M41678 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP | 9.85e-04 | 198 | 100 | 5 | M5222 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 9.97e-04 | 115 | 100 | 4 | M45752 | |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 9.97e-04 | 115 | 100 | 4 | M19068 | |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP | 1.01e-03 | 199 | 100 | 5 | M8119 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.01e-03 | 199 | 100 | 5 | M7254 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN | 1.03e-03 | 200 | 100 | 5 | M6258 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | GPM6B HSPG2 LAMA2 LAMA5 LAMB1 LAMB2 FBN1 HMCN1 TENM3 SLIT3 LTBP3 ADGRL2 TNXB NOTCH3 | 3.91e-08 | 466 | 100 | 14 | GSM777050_500 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | GPM6B NID2 HSPG2 LAMB1 LAMB2 SNED1 FBN1 TENM3 SLIT3 ADGRL2 TNXB NOTCH3 | 1.55e-06 | 455 | 100 | 12 | GSM777055_500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 3.02e-06 | 188 | 100 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | HSPG2 LAMA2 LAMB1 LAMB2 SNED1 ITGBL1 FBN1 HMCN1 TENM3 SLIT3 TNXB | 6.77e-06 | 437 | 100 | 11 | GSM777046_500 |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | NID2 HSPG2 STAB2 LAMB1 LAMC2 STAB1 SEMA3D FBN1 HMCN1 TM4SF1 PEAR1 | 7.07e-06 | 439 | 100 | 11 | GSM777059_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | GPM6B NID2 HSPG2 LAMA2 LAMB1 LAMB2 FBN1 TENM3 SLIT3 TM4SF1 TNXB | 8.03e-06 | 445 | 100 | 11 | GSM777043_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | HSPG2 LAMA2 LAMA5 LAMB1 LAMB2 FBN1 SLIT3 ADGRL2 TM4SF1 TNXB NOTCH3 | 9.49e-06 | 453 | 100 | 11 | GSM777067_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.31e-05 | 165 | 100 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 1.48e-05 | 388 | 100 | 10 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | FRAS1 IKZF2 COL16A1 LAMA5 OIP5 TENM2 ITGB6 ACSL4 SNED1 SEMA3D TNN DLL3 UNKL ZFHX3 LTBP3 | 4.89e-05 | 973 | 100 | 15 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.82e-05 | 283 | 100 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K3 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 6.16e-05 | 459 | 100 | 10 | GSM777037_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.36e-05 | 89 | 100 | 5 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.57e-05 | 288 | 100 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 6.68e-05 | 146 | 100 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 7.07e-05 | 91 | 100 | 5 | GSM777059_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | GPM6B FRAS1 PEG10 LAMA2 LAMB1 SEMA3D FBN1 FBN2 TENM4 HMCN1 TENM3 NR0B1 EGFLAM | 7.21e-05 | 777 | 100 | 13 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 9.10e-05 | 388 | 100 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | GPM6B FAT4 PEG10 LAMB1 SEMA3D FBN1 FBN2 TENM4 HMCN1 TENM3 NR0B1 ALAD ADGRL2 | 9.31e-05 | 797 | 100 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.10e-04 | 310 | 100 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | NID2 HSPG2 FAT4 STAB2 GNE PEG10 LAMB1 STAB1 HMCN1 NR0B1 ADGRL2 TM4SF1 NOTCH1 | 1.41e-04 | 831 | 100 | 13 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.42e-04 | 240 | 100 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 1.60e-04 | 418 | 100 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | placenta | 2.46e-04 | 349 | 100 | 8 | placenta | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.52e-04 | 65 | 100 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.60e-04 | 265 | 100 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | GPM6B LAMA2 LAMB1 SEMA3D FBN1 FBN2 TENM4 HMCN1 TENM3 NR0B1 EGFLAM ADGRL2 | 2.62e-04 | 768 | 100 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 2.86e-04 | 357 | 100 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | NID2 FRAS1 LAMA2 LAMB2 ITGBL1 SEMA3D FBN1 HMCN1 EGFLAM LTBP3 TM4SF1 TNXB | 2.94e-04 | 778 | 100 | 12 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 3.04e-04 | 456 | 100 | 9 | GSM777032_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | NID2 FRAS1 LAMA5 LAMB1 LAMC2 SEMA3D FBN1 FBN2 TENM4 TENM3 SUSD1 NOTCH1 | 3.12e-04 | 783 | 100 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 3.15e-04 | 194 | 100 | 6 | gudmap_kidney_P0_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 3.38e-04 | 127 | 100 | 5 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | GPM6B COL7A1 FAT4 COL16A1 LAMA2 STAB1 MST1 SNED1 SEMA3D FBN1 FBN2 TENM4 FAM193A HMCN1 SLIT3 | 3.56e-04 | 1166 | 100 | 15 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.57e-04 | 369 | 100 | 8 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.61e-04 | 199 | 100 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.70e-04 | 281 | 100 | 7 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.70e-04 | 281 | 100 | 7 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 3.70e-04 | 371 | 100 | 8 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | BM Top 100 - kidney medulla | 4.14e-04 | 74 | 100 | 4 | BM Top 100 - kidney medulla | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 4.45e-04 | 207 | 100 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | FAT4 IKZF2 MBOAT7 LAMB1 TENM2 FBN2 TENM4 FAM193A EHMT2 ZFHX3 ZNF646 SENP5 | 4.62e-04 | 818 | 100 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.75e-04 | 293 | 100 | 7 | gudmap_developingGonad_e18.5_testes_1000_k4 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 4.85e-04 | 294 | 100 | 7 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_500 | 6.11e-04 | 82 | 100 | 4 | gudmap_developingGonad_e12.5_testes_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 6.11e-04 | 82 | 100 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | GPM6B NID2 HSPG2 STAB2 PEG10 LAMB1 STAB1 ACSL4 HMCN1 NR0B1 TM4SF1 NOTCH1 | 6.22e-04 | 846 | 100 | 12 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 6.39e-04 | 146 | 100 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | GPM6B TNFRSF25 COL7A1 OBSCN MIB2 IKZF4 CRB1 JAG2 SEMA3D TENM4 EHMT2 ADGRL2 FBN3 NOTCH1 CRB2 | 7.06e-04 | 1245 | 100 | 15 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | GPM6B COL7A1 IKZF2 COL16A1 LAMA5 TENM2 ITGB6 SNED1 SEMA3D TNN ZFHX3 LTBP3 MUC4 | 7.11e-04 | 984 | 100 | 13 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | GPM6B FAT4 PEG10 SEMA3D FBN1 FBN2 TENM4 HMCN1 TENM3 NR0B1 ADGRL2 | 7.23e-04 | 740 | 100 | 11 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500 | 7.61e-04 | 414 | 100 | 8 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 7.64e-04 | 87 | 100 | 4 | GSM791122_100 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | NID2 HSPG2 FRAS1 COL16A1 PEG10 LAMA3 LAMB1 LAMC2 ITGB6 SUSD1 SLIT3 | 9.09e-04 | 761 | 100 | 11 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | FAT4 LAMA2 IKZF4 SNED1 SEMA3D FBN1 FBN2 TENM4 FAM193A HMCN1 TENM3 SLIT3 EGFLAM LTBP3 | 9.60e-04 | 1148 | 100 | 14 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | COL7A1 FAT4 IKZF2 LAMA3 TENM2 SEMA3D FAM193A HMCN1 MEGF9 TENM1 ZFHX3 | 9.90e-04 | 769 | 100 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.02e-03 | 42 | 100 | 3 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.02e-03 | 42 | 100 | 3 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.06e-03 | 336 | 100 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.10e-03 | 96 | 100 | 4 | GSM777063_100 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_top-relative-expression-ranked_200 | 1.14e-03 | 166 | 100 | 5 | gudmap_developingGonad_e18.5_testes_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | GPM6B FAT4 PEG10 SEMA3D FBN1 FBN2 TENM4 HMCN1 TENM3 NR0B1 ADGRL2 | 1.14e-03 | 783 | 100 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.15e-03 | 97 | 100 | 4 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.15e-03 | 97 | 100 | 4 | GSM777046_100 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | GPM6B FAT4 IKZF4 SNED1 SEMA3D FBN1 FBN2 HMCN1 ZFHX3 LTBP3 ADGRL2 | 1.24e-03 | 791 | 100 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | 1.30e-03 | 450 | 100 | 8 | GSM777063_500 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | WBP1 NID2 COL7A1 LAMB1 LAMB2 MIB2 MST1 FBN1 FBN2 SCUBE2 EGF MEGF6 PRMT2 ALAD FBN3 CRB2 | 1.32e-03 | 1466 | 100 | 16 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | GGNBP2 COL16A1 LAMA2 IKZF4 ITGBL1 SEMA3D MEGF6 SLIT3 LRP6 EGFLAM TNXB | 1.35e-03 | 799 | 100 | 11 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.42e-03 | 259 | 100 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.43e-03 | 354 | 100 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | FAT4 IKZF2 LAMA3 TENM2 IKZF4 SEMA3D TENM4 FAM193A HMCN1 MEGF11 ZNF646 | 1.44e-03 | 806 | 100 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.48e-03 | 261 | 100 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NID2 HSPG2 COL16A1 LAMA2 LAMB1 LAMB2 SNED1 ITGBL1 SEMA3D FBN1 SLIT3 LTBP3 | 2.83e-14 | 196 | 101 | 12 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NID2 HSPG2 COL16A1 LAMA2 LAMB1 LAMB2 SNED1 ITGBL1 SEMA3D FBN1 SLIT3 LTBP3 | 2.83e-14 | 196 | 101 | 12 | 787c6cd92035e0b1108c2c086c42a229016e476b |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 FRAS1 STAB2 OBSCN MUC5B SSPOP FBN2 TENM4 HMCN1 OTOGL TENM1 | 4.57e-13 | 184 | 101 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 FRAS1 STAB2 OBSCN MUC5B SSPOP FBN2 TENM4 HMCN1 OTOGL TENM1 | 4.57e-13 | 184 | 101 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | FAT4 FRAS1 STAB2 OBSCN MUC5B SSPOP FBN2 TENM4 HMCN1 OTOGL TENM1 | 4.57e-13 | 184 | 101 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | FAT4 LAMA2 LAMB1 TENM2 ITGBL1 FBN1 TENM4 HMCN1 SLIT3 ADGRL2 TNXB | 5.46e-13 | 187 | 101 | 11 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | GPM6B FAT4 FRAS1 LAMA2 LAMB1 ITGBL1 FBN1 HMCN1 TENM3 SLIT3 TNXB | 6.88e-13 | 191 | 101 | 11 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FAT4 COL16A1 LAMA2 LAMB1 ITGBL1 FBN1 TENM4 HMCN1 SLIT3 TENM1 TNXB | 9.65e-13 | 197 | 101 | 11 | 44673c38384453207871d3fd8e8ba9093cc06bc5 |
| ToppCell | Basal|World / shred by cell class for mouse tongue | COL7A1 COL16A1 LAMA3 LAMA5 LAMB1 LAMC2 ITGB4 JAG2 MEGF6 ZFHX3 | 1.35e-11 | 183 | 101 | 10 | c6729a207526ff4aa48176207b9353176f631fea |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.67e-11 | 187 | 101 | 10 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HSPG2 COL16A1 LAMA2 LAMB1 ITGBL1 SEMA3D FBN1 SLIT3 LTBP3 TNXB | 2.17e-11 | 192 | 101 | 10 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-11 | 192 | 101 | 10 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HSPG2 COL16A1 LAMA2 LAMB1 ITGBL1 SEMA3D FBN1 SLIT3 LTBP3 TNXB | 2.17e-11 | 192 | 101 | 10 | eeab1cef7c36ae824381952c5b2c982368c379fd |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-11 | 192 | 101 | 10 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-11 | 192 | 101 | 10 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-11 | 193 | 101 | 10 | 858a186804b36d45957238d3d3eed2768b961641 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-11 | 193 | 101 | 10 | 7865e7ec0a288249540d4cba94ae01c93e1b617c | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.53e-11 | 195 | 101 | 10 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-11 | 195 | 101 | 10 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | COL16A1 LAMA2 LAMB1 SNED1 ITGBL1 FBN1 TENM4 HMCN1 TENM3 SLIT3 | 2.80e-11 | 197 | 101 | 10 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | FRAS1 COL16A1 LAMA2 LAMB1 SNED1 ITGBL1 FBN1 HMCN1 TENM3 SLIT3 | 2.94e-11 | 198 | 101 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | FAT4 COL16A1 LAMA2 LAMB1 SNED1 SEMA3D FBN1 HMCN1 TENM3 SLIT3 | 2.94e-11 | 198 | 101 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-11 | 199 | 101 | 10 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.09e-11 | 199 | 101 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | FAT4 COL16A1 LAMA2 LAMB1 ITGBL1 FBN1 TENM4 TENM3 SLIT3 ZFHX3 | 3.09e-11 | 199 | 101 | 10 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-11 | 200 | 101 | 10 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | GPM6B FRAS1 COL16A1 LAMA2 LAMB1 ITGBL1 FBN1 HMCN1 SLIT3 TNXB | 3.25e-11 | 200 | 101 | 10 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-11 | 200 | 101 | 10 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.68e-10 | 167 | 101 | 9 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.43e-10 | 181 | 101 | 9 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-10 | 186 | 101 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.58e-10 | 187 | 101 | 9 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.58e-10 | 187 | 101 | 9 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-10 | 189 | 101 | 9 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 5.04e-10 | 189 | 101 | 9 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-10 | 189 | 101 | 9 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-10 | 189 | 101 | 9 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.28e-10 | 190 | 101 | 9 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.28e-10 | 190 | 101 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-10 | 190 | 101 | 9 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-10 | 191 | 101 | 9 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-10 | 191 | 101 | 9 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.53e-10 | 191 | 101 | 9 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-10 | 191 | 101 | 9 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.79e-10 | 192 | 101 | 9 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-10 | 192 | 101 | 9 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.79e-10 | 192 | 101 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.06e-10 | 193 | 101 | 9 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-10 | 193 | 101 | 9 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.06e-10 | 193 | 101 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.06e-10 | 193 | 101 | 9 | 025836c5c5a711e477c326559e618e47cae42d11 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.06e-10 | 193 | 101 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 6.34e-10 | 194 | 101 | 9 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-10 | 195 | 101 | 9 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-10 | 195 | 101 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-10 | 195 | 101 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-10 | 195 | 101 | 9 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-10 | 195 | 101 | 9 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-10 | 196 | 101 | 9 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-10 | 196 | 101 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 6.95e-10 | 196 | 101 | 9 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-10 | 196 | 101 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.95e-10 | 196 | 101 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.95e-10 | 196 | 101 | 9 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.95e-10 | 196 | 101 | 9 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.26e-10 | 197 | 101 | 9 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 7.26e-10 | 197 | 101 | 9 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.26e-10 | 197 | 101 | 9 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.60e-10 | 198 | 101 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.60e-10 | 198 | 101 | 9 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.94e-10 | 199 | 101 | 9 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.94e-10 | 199 | 101 | 9 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.94e-10 | 199 | 101 | 9 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.30e-10 | 200 | 101 | 9 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-10 | 200 | 101 | 9 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-10 | 200 | 101 | 9 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-10 | 200 | 101 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-10 | 200 | 101 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 8.30e-10 | 200 | 101 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-10 | 200 | 101 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.30e-10 | 200 | 101 | 9 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.04e-09 | 169 | 101 | 8 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-09 | 171 | 101 | 8 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.53e-09 | 171 | 101 | 8 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.79e-09 | 172 | 101 | 8 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.63e-09 | 175 | 101 | 8 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.63e-09 | 181 | 101 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.01e-09 | 182 | 101 | 8 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-08 | 185 | 101 | 8 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-08 | 185 | 101 | 8 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-08 | 186 | 101 | 8 | c0a036096c2cb23305605b8aaf18869d6e0fb512 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-08 | 186 | 101 | 8 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-08 | 188 | 101 | 8 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-08 | 188 | 101 | 8 | 26915db8863f4115b46a81982e187322e21600fd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-08 | 188 | 101 | 8 | 3f76c0f912f8f023ea425be7f43593b3d7f967e3 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-08 | 188 | 101 | 8 | 61ee7b152745164293d8a44ef91ee2393efbdca5 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-08 | 189 | 101 | 8 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-08 | 189 | 101 | 8 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-08 | 189 | 101 | 8 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-08 | 190 | 101 | 8 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| Computational | Adhesion molecules. | COL7A1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGBL1 FBN1 FBN2 TNXB | 2.00e-11 | 141 | 62 | 12 | MODULE_122 |
| Computational | Intermediate filaments. | 2.19e-07 | 75 | 62 | 7 | MODULE_154 | |
| Computational | Intermediate filaments and keratins. | 3.43e-07 | 80 | 62 | 7 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 3.43e-07 | 80 | 62 | 7 | MODULE_297 | |
| Computational | Trachea genes. | HSPG2 TNFRSF25 GNE LAMA5 LAMB2 MUC5B ITGB4 STAB1 FCGBP TM4SF1 MUC4 TNXB NOTCH3 | 5.20e-07 | 415 | 62 | 13 | MODULE_6 |
| Computational | Placenta genes. | HSPG2 TNFRSF25 GNE PEG10 LAMA5 LAMB2 ITGB4 STAB1 FBN2 FCGBP TM4SF1 TNXB NOTCH3 | 1.79e-06 | 463 | 62 | 13 | MODULE_38 |
| Computational | Ovary genes. | NID2 HSPG2 COL16A1 PEG10 LAMB1 LAMB2 STAB1 FBN1 TM4SF1 TNXB NOTCH3 | 6.91e-06 | 368 | 62 | 11 | MODULE_1 |
| Computational | DRG (dorsal root ganglia) genes. | HSPG2 LAMA5 LAMB1 LAMB2 ITGB4 STAB1 FBN1 MEGF9 TM4SF1 TNXB NOTCH3 | 1.03e-05 | 384 | 62 | 11 | MODULE_2 |
| Computational | Fetal liver genes - metabolism and xenobiotics. | HSPG2 TNFRSF25 PEG10 LAMB2 F12 STAB1 MST1 ACSL4 FBN2 MEGF9 TNXB | 4.79e-05 | 453 | 62 | 11 | MODULE_24 |
| Computational | Metal / Ca ion binding. | 1.12e-04 | 133 | 62 | 6 | MODULE_324 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.89e-04 | 50 | 62 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2 | |
| Computational | Spinal cord (neuro-development) genes. | 2.03e-04 | 360 | 62 | 9 | MODULE_12 | |
| Computational | Intermediate filaments and MT. | 6.20e-04 | 68 | 62 | 4 | MODULE_438 | |
| Computational | Genes in the cancer module 55. | HSPG2 TNFRSF25 COL7A1 GNE PEG10 LAMB2 MUC5B F12 STAB1 MST1 FBN2 TM4SF1 TNXB | 7.70e-04 | 832 | 62 | 13 | MODULE_55 |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | HSPG2 COL7A1 GNE PEG10 LAMB2 MUC5B F12 STAB1 MST1 FBN2 FCGBP TM4SF1 TNXB | 7.96e-04 | 835 | 62 | 13 | MODULE_88 |
| Computational | Genes in the cancer module 153. | 9.63e-04 | 34 | 62 | 3 | MODULE_153 | |
| Computational | Liver genes - metabolism and xenobiotics. | 1.31e-03 | 563 | 62 | 10 | MODULE_23 | |
| Computational | Serine proteases. | 1.44e-03 | 39 | 62 | 3 | MODULE_109 | |
| Computational | Developmental processes. | 2.93e-03 | 333 | 62 | 7 | MODULE_220 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.95e-03 | 50 | 62 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.95e-03 | 50 | 62 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Lung genes. | 3.30e-03 | 434 | 62 | 8 | MODULE_5 | |
| Drug | AC1L1G72 | 8.28e-15 | 11 | 100 | 7 | CID000003553 | |
| Drug | kalinin | HSPG2 LAMB4 COL7A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 | 4.18e-14 | 55 | 100 | 10 | CID000032518 |
| Drug | AC1L1B58 | 3.67e-11 | 29 | 100 | 7 | CID000001288 | |
| Drug | Rgd Peptide | LAMB4 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 ITGB6 FBN1 FBN2 EGF TNXB FBN3 | 4.30e-11 | 239 | 100 | 13 | CID000104802 |
| Drug | AC1L1C2F | NID2 HSPG2 COL7A1 COL16A1 LAMA3 LAMA5 LAMB1 LAMC2 ITGB4 KCNMB3 | 5.50e-11 | 110 | 100 | 10 | CID000001711 |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.06e-10 | 83 | 100 | 9 | CID011968896 | |
| Drug | CC270 | 1.92e-10 | 59 | 100 | 8 | CID006918852 | |
| Drug | AC1L9INI | 1.92e-10 | 59 | 100 | 8 | CID000445839 | |
| Drug | Calcort | 2.88e-10 | 38 | 100 | 7 | CID000026709 | |
| Drug | BM165 | 6.68e-10 | 11 | 100 | 5 | CID003352881 | |
| Drug | 2-amino-5-methylpyridine | 1.71e-09 | 77 | 100 | 8 | CID000015348 | |
| Drug | hyaluronan | HSPG2 COL7A1 COL16A1 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 FBN1 FBN2 EGF TNXB | 1.87e-09 | 263 | 100 | 12 | CID000024759 |
| Drug | NSC 714187 | 3.79e-09 | 85 | 100 | 8 | CID005288693 | |
| Drug | 1,2-dimethylhydrazine | 4.17e-09 | 86 | 100 | 8 | CID000001322 | |
| Drug | LG 5 | 8.13e-09 | 60 | 100 | 7 | CID011840957 | |
| Drug | ALT-711 | 2.84e-08 | 21 | 100 | 5 | CID000216304 | |
| Drug | dysprosium | 3.60e-08 | 74 | 100 | 7 | CID000023912 | |
| Drug | B-Ms | 3.91e-08 | 114 | 100 | 8 | CID000445091 | |
| Drug | YIGSR | 5.70e-08 | 79 | 100 | 7 | CID000123977 | |
| Drug | Sikvav | 5.88e-08 | 24 | 100 | 5 | CID005487517 | |
| Drug | H-9 dihydrochloride | 1.41e-07 | 90 | 100 | 7 | CID000003544 | |
| Drug | LMWH | NID2 HSPG2 LAMB4 COL7A1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 F12 PROZ EGF TNXB | 2.01e-07 | 663 | 100 | 15 | CID000000772 |
| Drug | Pipemidic acid [51940-44-4]; Up 200; 13.2uM; HL60; HT_HG-U133A | 2.28e-07 | 198 | 100 | 9 | 3093_UP | |
| Drug | AC1O0B8G | 2.39e-07 | 262 | 100 | 10 | CID000091605 | |
| Drug | UNC0642 | 3.28e-07 | 4 | 100 | 3 | ctd:C000621860 | |
| Drug | I-Q-S | 4.43e-07 | 156 | 100 | 8 | CID000003540 | |
| Drug | Ikvav | 6.61e-07 | 38 | 100 | 5 | CID000131343 | |
| Drug | quinaprilat | 1.25e-06 | 43 | 100 | 5 | CID000107994 | |
| Drug | YM 155 | 1.63e-06 | 6 | 100 | 3 | ctd:C523798 | |
| Drug | Grgds | 1.77e-06 | 83 | 100 | 6 | CID000123811 | |
| Drug | chondroitin sulfate | HSPG2 COL7A1 COL16A1 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ACSL4 EGF TNXB | 2.04e-06 | 413 | 100 | 11 | CID000024766 |
| Drug | Ganciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 2.47e-06 | 196 | 100 | 8 | 3368_UP | |
| Drug | Bicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.57e-06 | 197 | 100 | 8 | 4397_UP | |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.67e-06 | 198 | 100 | 8 | 4145_UP | |
| Drug | trypanothione disulfide | 2.84e-06 | 140 | 100 | 7 | CID000115098 | |
| Drug | 2,4-diaminopyrimidine | 3.94e-06 | 54 | 100 | 5 | CID000067431 | |
| Drug | colchine | LAMB4 COL7A1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 EGF | 7.28e-06 | 383 | 100 | 10 | CID000002833 |
| Drug | AC1L1KMJ | LAMB4 COL7A1 COL16A1 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 EGF ADGRL2 | 7.89e-06 | 476 | 100 | 11 | CID000030956 |
| Drug | Gdrgdsp | 8.67e-06 | 109 | 100 | 6 | CID000115346 | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | NID2 TNFRSF25 LAMB4 COL16A1 SLC17A4 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 JAG2 ACSL3 EGF TNN | 9.91e-06 | 909 | 100 | 15 | CID000002524 |
| Drug | DB04780 | 1.02e-05 | 170 | 100 | 7 | CID005459389 | |
| Drug | rosavin | 1.15e-05 | 32 | 100 | 4 | ctd:C529148 | |
| Drug | geldanamycin; Up 200; 1uM; HL60; HT_HG-U133A | 1.59e-05 | 182 | 100 | 7 | 2688_UP | |
| Drug | 7-(2-(2-(dimethylamino)ethoxy)ethoxy)-6-methoxy-2-(4-methyl-1,4-diazepan-1-yl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine | 1.91e-05 | 2 | 100 | 2 | ctd:C551961 | |
| Drug | N-(1-cyclohexylpiperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine | 1.91e-05 | 2 | 100 | 2 | ctd:C562047 | |
| Drug | A0395 | 2.00e-05 | 75 | 100 | 5 | CID009906466 | |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 2.03e-05 | 189 | 100 | 7 | 2729_UP | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; MCF7; HT_HG-U133A | 2.32e-05 | 193 | 100 | 7 | 6100_UP | |
| Drug | Verteporfin [129497-78-5]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 2.40e-05 | 194 | 100 | 7 | 3556_UP | |
| Drug | Tetrandrine [518-34-3]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 2.48e-05 | 195 | 100 | 7 | 6082_DN | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 6027_UP | |
| Drug | CGX 0596987; Up 200; 20uM; MCF7; HT_HG-U133A | 2.56e-05 | 196 | 100 | 7 | 6364_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 5633_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.65e-05 | 197 | 100 | 7 | 4754_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.74e-05 | 198 | 100 | 7 | 2271_UP | |
| Drug | dexamethasone; Down 200; 1uM; ssMCF7; HG-U133A | 2.92e-05 | 200 | 100 | 7 | 374_DN | |
| Drug | lead stearate | 3.47e-05 | 84 | 100 | 5 | CID000061258 | |
| Drug | taxol | LAMB4 PEG10 LAMA2 LAMA3 LAMA5 LAMB1 LAMB2 LAMC2 ITGB4 PGR EGF | 3.54e-05 | 560 | 100 | 11 | CID000004666 |
| Drug | poly-N-acetyllactosamine | 4.34e-05 | 88 | 100 | 5 | CID000119547 | |
| Drug | dermatan sulfate | 5.35e-05 | 220 | 100 | 7 | CID000032756 | |
| Drug | pyrachlostrobin | NID2 HSPG2 COL16A1 PHF19 PEG10 LAMA5 LAMB2 STAB1 FBN1 LTBP3 NOTCH1 NOTCH3 CRB2 | 5.51e-05 | 811 | 100 | 13 | ctd:C513428 |
| Drug | cobalt-60 | 5.58e-05 | 390 | 100 | 9 | CID000061492 | |
| Drug | B-08 | 5.71e-05 | 3 | 100 | 2 | CID016086421 | |
| Drug | AC1L2XHC | 5.71e-05 | 3 | 100 | 2 | CID000130491 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 6.36e-05 | 155 | 100 | 6 | 6817_DN | |
| Drug | VAI2 | 6.92e-05 | 97 | 100 | 5 | CID003474204 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 7.42e-05 | 314 | 100 | 8 | CID000003542 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 7.42e-05 | 314 | 100 | 8 | CID000447989 | |
| Drug | Rgds Peptide | 1.05e-04 | 106 | 100 | 5 | CID000107775 | |
| Drug | AC1L2XH9 | 1.14e-04 | 4 | 100 | 2 | CID000130490 | |
| Drug | cyclohexylmagnesium chloride | 1.14e-04 | 4 | 100 | 2 | CID000013605 | |
| Drug | dithiotreitol | 1.17e-04 | 430 | 100 | 9 | CID000019001 | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 1.40e-04 | 179 | 100 | 6 | 4452_UP | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 1.83e-04 | 188 | 100 | 6 | 5958_DN | |
| Drug | NaCl | 1.89e-04 | 564 | 100 | 10 | CID000005234 | |
| Drug | zinc diethylenetriaminepentaacetate | 1.89e-04 | 5 | 100 | 2 | CID000025464 | |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.00e-04 | 191 | 100 | 6 | 7100_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.05e-04 | 192 | 100 | 6 | 4175_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A | 2.05e-04 | 192 | 100 | 6 | 3858_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 100 | 6 | 6846_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 1223_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 3855_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 3610_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.17e-04 | 194 | 100 | 6 | 4269_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 2000uM; MCF7; HG-U133A | 2.17e-04 | 194 | 100 | 6 | 346_UP | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 2538_UP | |
| Drug | Benperidol [2062-84-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 4781_UP | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; HL60; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 3078_UP | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.23e-04 | 195 | 100 | 6 | 4355_UP | |
| Drug | Selara | 2.28e-04 | 125 | 100 | 5 | CID000150310 | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 4119_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 3375_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 2783_UP | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 3847_UP | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 2862_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 5757_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 6060_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 2.30e-04 | 196 | 100 | 6 | 7495_DN | |
| Drug | Reidispongiolide C | 2.33e-04 | 279 | 100 | 7 | CID005289285 | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.36e-04 | 197 | 100 | 6 | 6099_UP | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.23e-08 | 3 | 95 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | Herlitz Disease | 1.29e-07 | 4 | 95 | 3 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 1.29e-07 | 4 | 95 | 3 | C0079297 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 3.22e-07 | 5 | 95 | 3 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 3.22e-07 | 5 | 95 | 3 | C2608084 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 3.22e-07 | 5 | 95 | 3 | DOID:3030 (is_marker_for) | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 3.22e-07 | 5 | 95 | 3 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 6.42e-07 | 6 | 95 | 3 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 1.12e-06 | 7 | 95 | 3 | DOID:3209 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | NID2 COL7A1 UBR4 OBSCN LAMA2 PGR JAG2 MST1 EGF OTOGL TENM1 EHMT1 NOTCH1 NOTCH3 ZNF646 | 1.71e-06 | 1074 | 95 | 15 | C0006142 |
| Disease | Amelogenesis Imperfecta | 6.96e-06 | 12 | 95 | 3 | C0002452 | |
| Disease | Kleefstra syndrome 1 (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0060352 (implicated_via_orthology) | |
| Disease | non-syndromic X-linked intellectual disability 63 (implicated_via_orthology) | 1.03e-05 | 2 | 95 | 2 | DOID:0112050 (implicated_via_orthology) | |
| Disease | Junctional epidermolysis bullosa | 3.07e-05 | 3 | 95 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 3.07e-05 | 3 | 95 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 3.07e-05 | 3 | 95 | 2 | 226700 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.52e-05 | 64 | 95 | 4 | DOID:4947 (is_marker_for) | |
| Disease | scoliosis (is_implicated_in) | 6.13e-05 | 4 | 95 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Carcinoma, Pancreatic Ductal | 6.23e-05 | 24 | 95 | 3 | C0887833 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 7.06e-05 | 25 | 95 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | taurine measurement | 7.97e-05 | 26 | 95 | 3 | EFO_0010536 | |
| Disease | Geleophysic dysplasia | 1.02e-04 | 5 | 95 | 2 | C3489726 | |
| Disease | viral infectious disease (implicated_via_orthology) | 1.02e-04 | 5 | 95 | 2 | DOID:934 (implicated_via_orthology) | |
| Disease | Acromicric Dysplasia | 1.02e-04 | 5 | 95 | 2 | C0265287 | |
| Disease | mucositis (biomarker_via_orthology) | 1.02e-04 | 5 | 95 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 1.02e-04 | 5 | 95 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | response to silica exposure, pneumoconiosis | 1.02e-04 | 5 | 95 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | ulcerative colitis | 1.07e-04 | 335 | 95 | 7 | EFO_0000729 | |
| Disease | Glioblastoma | 1.26e-04 | 79 | 95 | 4 | C0017636 | |
| Disease | Sjogren-Larsson syndrome (implicated_via_orthology) | 1.53e-04 | 6 | 95 | 2 | DOID:14501 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 1.53e-04 | 156 | 95 | 5 | C0376634 | |
| Disease | FEV/FEC ratio | NID2 HSPG2 FRAS1 LAMC2 IKZF4 FBN1 FCGBP HMCN1 MEGF6 ZFHX3 LTBP3 TNXB CRB2 | 1.55e-04 | 1228 | 95 | 13 | EFO_0004713 |
| Disease | Giant Cell Glioblastoma | 1.60e-04 | 84 | 95 | 4 | C0334588 | |
| Disease | liver cirrhosis (biomarker_via_orthology) | 1.80e-04 | 34 | 95 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 2.13e-04 | 7 | 95 | 2 | C0399367 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.13e-04 | 7 | 95 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.13e-04 | 7 | 95 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of esophagus | 2.57e-04 | 95 | 95 | 4 | C0279626 | |
| Disease | Scoliosis, unspecified | 2.84e-04 | 8 | 95 | 2 | C0036439 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 3.64e-04 | 9 | 95 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 3.64e-04 | 9 | 95 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | otitis media (is_marker_for) | 4.54e-04 | 10 | 95 | 2 | DOID:10754 (is_marker_for) | |
| Disease | allergic conjunctivitis (is_marker_for) | 4.54e-04 | 10 | 95 | 2 | DOID:11204 (is_marker_for) | |
| Disease | Glioblastoma Multiforme | 4.64e-04 | 111 | 95 | 4 | C1621958 | |
| Disease | Carcinoma, Granular Cell | 5.48e-04 | 116 | 95 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 5.48e-04 | 116 | 95 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 5.48e-04 | 116 | 95 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 5.48e-04 | 116 | 95 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 5.48e-04 | 116 | 95 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 5.48e-04 | 116 | 95 | 4 | C0001418 | |
| Disease | Congenital Abnormality | 5.54e-04 | 11 | 95 | 2 | C0000768 | |
| Disease | peptidyl-glycine alpha-amidating monooxygenase measurement | 5.54e-04 | 11 | 95 | 2 | EFO_0801871 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 6.14e-04 | 447 | 95 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Clear Cell Meningioma | 6.63e-04 | 12 | 95 | 2 | C0431121 | |
| Disease | Intraventricular Meningioma | 6.63e-04 | 12 | 95 | 2 | C1334271 | |
| Disease | Benign Meningioma | 6.63e-04 | 12 | 95 | 2 | C0281784 | |
| Disease | Intraorbital Meningioma | 6.63e-04 | 12 | 95 | 2 | C1334261 | |
| Disease | Olfactory Groove Meningioma | 6.63e-04 | 12 | 95 | 2 | C1335107 | |
| Disease | Angioblastic Meningioma | 6.63e-04 | 12 | 95 | 2 | C1527197 | |
| Disease | Meningiomas, Multiple | 6.63e-04 | 12 | 95 | 2 | C0205834 | |
| Disease | Xanthomatous Meningioma | 6.63e-04 | 12 | 95 | 2 | C0457190 | |
| Disease | Angiomatous Meningioma | 6.63e-04 | 12 | 95 | 2 | C0334608 | |
| Disease | Psammomatous Meningioma | 6.63e-04 | 12 | 95 | 2 | C0334607 | |
| Disease | Fibrous Meningioma | 6.63e-04 | 12 | 95 | 2 | C0334606 | |
| Disease | Meningothelial meningioma | 6.63e-04 | 12 | 95 | 2 | C0334605 | |
| Disease | Hemangioblastic Meningioma | 6.63e-04 | 12 | 95 | 2 | C0334609 | |
| Disease | Transitional Meningioma | 6.63e-04 | 12 | 95 | 2 | C0334611 | |
| Disease | Hemangiopericytic Meningioma | 6.63e-04 | 12 | 95 | 2 | C0334610 | |
| Disease | Spinal Meningioma | 6.63e-04 | 12 | 95 | 2 | C0347515 | |
| Disease | Intracranial Meningioma | 6.63e-04 | 12 | 95 | 2 | C0349604 | |
| Disease | Papillary Meningioma | 6.63e-04 | 12 | 95 | 2 | C3163622 | |
| Disease | Malignant Meningioma | 6.63e-04 | 12 | 95 | 2 | C0259785 | |
| Disease | Sphenoid Wing Meningioma | 6.63e-04 | 12 | 95 | 2 | C1565951 | |
| Disease | Posterior Fossa Meningioma | 6.63e-04 | 12 | 95 | 2 | C1565950 | |
| Disease | Parasagittal Meningioma | 6.63e-04 | 12 | 95 | 2 | C0751304 | |
| Disease | Cerebral Convexity Meningioma | 6.63e-04 | 12 | 95 | 2 | C0751303 | |
| Disease | Microcystic meningioma | 6.63e-04 | 12 | 95 | 2 | C1384408 | |
| Disease | Secretory meningioma | 6.63e-04 | 12 | 95 | 2 | C1384406 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.74e-04 | 53 | 95 | 3 | C4707243 | |
| Disease | verbal-numerical reasoning measurement | 8.64e-04 | 131 | 95 | 4 | EFO_0008394 | |
| Disease | urate measurement, bone density | 8.80e-04 | 619 | 95 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | cortical thickness | HSPG2 SEM1 LAMA2 TENM2 STAB1 JAG2 FBN1 FBN2 MALRD1 MEGF9 CRB2 | 9.05e-04 | 1113 | 95 | 11 | EFO_0004840 |
| Disease | Hypodontia | 9.10e-04 | 14 | 95 | 2 | C0020608 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.02e-03 | 61 | 95 | 3 | DOID:3587 (is_marker_for) | |
| Disease | caffeine measurement | 1.05e-03 | 15 | 95 | 2 | EFO_0021177 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.20e-03 | 16 | 95 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.20e-03 | 16 | 95 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.20e-03 | 16 | 95 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.20e-03 | 16 | 95 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.20e-03 | 16 | 95 | 2 | C0025237 | |
| Disease | cortical surface area measurement | SEM1 LAMA2 TENM2 JAG2 SEMA3D FBN1 FBN2 MEGF6 ZFHX3 ADGRL2 TNXB FBN3 | 1.27e-03 | 1345 | 95 | 12 | EFO_0010736 |
| Disease | Van Buchem disease | 1.35e-03 | 17 | 95 | 2 | C0432272 | |
| Disease | sex interaction measurement, ulcerative colitis | 1.35e-03 | 17 | 95 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 1.51e-03 | 70 | 95 | 3 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | Child Behaviour Checklist assessment | 1.52e-03 | 18 | 95 | 2 | EFO_0005661 | |
| Disease | Mammary Carcinoma, Human | 1.56e-03 | 525 | 95 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.56e-03 | 525 | 95 | 7 | C1257931 | |
| Disease | amino acid measurement | 1.57e-03 | 678 | 95 | 8 | EFO_0005134 | |
| Disease | Mammary Neoplasms | 1.59e-03 | 527 | 95 | 7 | C1458155 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.65e-03 | 156 | 95 | 4 | C0007131 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCFCCPIGQGYGLTE | 456 | O60488 | |
| ERAGCCGYIPANHVG | 71 | P55345 | |
| YDCDCPLGFEGLHCQ | 806 | Q63HQ2 | |
| HPCGVQGCPAGYECK | 266 | Q15878 | |
| DGEPCFSCLYGNGPH | 501 | Q96Q27 | |
| CGDCVQGQRAHPGYL | 956 | Q07092 | |
| YCHCPFGVFGKHCEL | 3961 | Q6V0I7 | |
| GKCFRHSYCCGGLPT | 1096 | O95490 | |
| GCGYFCTAGTFLECH | 496 | Q96KQ7 | |
| AYICHCPPGFQGSNC | 336 | Q9NYJ7 | |
| GGRCYAHFSGLVCAC | 441 | Q9NYJ7 | |
| LGGYRCSCPQGFTQH | 2546 | Q75N90 | |
| CSYSCANTPGGFLCG | 2621 | Q75N90 | |
| CPQGYFRAGQGHCVS | 2636 | Q75N90 | |
| CCYCEFFGHGGPPAA | 791 | P78312 | |
| CPLFCDFYNPHGGCE | 1151 | Q9HC84 | |
| HNGTGYCKCPEGFLG | 6 | Q7Z3S9 | |
| PYLGTCSGCNCNGHA | 756 | P98160 | |
| TGSGLYLGHCELCEC | 1551 | P98160 | |
| VSPCSRGYCDHGGQC | 5321 | Q99102 | |
| GQHCEQRCAPGTFGY | 776 | A6BM72 | |
| SFYCECPHGRTGLLC | 356 | P46531 | |
| LHGGTCQDGCGSYRC | 1031 | P46531 | |
| RHGQCVPTCGDGFYQ | 491 | Q86XX4 | |
| TGHYGFPRCKPCSCG | 1301 | Q16787 | |
| SCGGFGFLPCSVCHG | 241 | A8MXD5 | |
| GYCAALYEGLRCCPH | 241 | Q9H3C7 | |
| CEGDYGGPLACFTHN | 661 | Q2TV78 | |
| GFQCHCPDGYAGPTC | 341 | Q5IJ48 | |
| VCLCPYTSHGHCGLL | 121 | P13716 | |
| GYQCVCPRGFGGRHC | 481 | Q9Y219 | |
| DCYCGQCICHLSPYG | 516 | P18564 | |
| SHCLEGFAPVDGCGC | 686 | Q02817 | |
| CHGFYESRGFCVPLC | 91 | Q5VY43 | |
| GLCQCAPGYTGPHCA | 421 | Q5VY43 | |
| HGICYDAPGGFRCVC | 706 | Q9UM47 | |
| TCPPGYGGFHCEQDL | 911 | Q9UM47 | |
| FSCLCRPGYTGAHCQ | 946 | Q9UM47 | |
| LYCGTGGHYADNCPA | 296 | Q86TG7 | |
| PCAEENGGCSHLCLY | 591 | O75581 | |
| AVPVGGFVCGCPAHY | 906 | O75581 | |
| AAECGCIAAGFGAYP | 251 | Q96N66 | |
| TGQCECRPGYQGLHC | 221 | Q9H1U4 | |
| CFCYGHASECAPVDG | 271 | P07942 | |
| GNCFCYGHASECAPA | 281 | P55268 | |
| YGFGPTGCQACQCSH | 821 | P55268 | |
| GECLNCKDHTGGPYC | 771 | P24043 | |
| FQGTHCELCAPGFYG | 521 | O15230 | |
| PGYFHFPLCQLCGCS | 576 | O15230 | |
| PGYHGFPNCQACTCD | 621 | O15230 | |
| GCFECCIKCLGGVPY | 21 | Q13491 | |
| GCHGYRDPLECNICG | 491 | Q9UKS7 | |
| GECQCGHCVCYGEGR | 516 | P16144 | |
| HNGTGYCKCPEGFLG | 6 | P0DPK4 | |
| CFNAIGSFHCGCEPG | 5206 | Q96RW7 | |
| GSFHCGCEPGYQLKG | 5211 | Q96RW7 | |
| LYRCCFCGEDHPQQG | 196 | P51843 | |
| GEYHCGLAQGSICPA | 4691 | Q5VST9 | |
| SCACLPGYAGDGHQC | 876 | Q14112 | |
| ICLICGDEASGCHYG | 566 | P06401 | |
| GFCPLGYRECHNGKC | 1481 | Q5VYJ5 | |
| GPDCSCGSHGCIEAY | 576 | Q9Y223 | |
| QPGCSCYHCSEGGEA | 11 | Q96Q40 | |
| GADPCLYQNGGCEHI | 741 | P01133 | |
| CPLSHDGYCLHDGVC | 976 | P01133 | |
| CVPVGQCGCLHDGRY | 4786 | Q9Y6R7 | |
| QCGCLHDGRYYPLGE | 4791 | Q9Y6R7 | |
| CQKGYIGTHCGQPVC | 136 | P35555 | |
| YGCSNTEGGYLCGCP | 2661 | P35555 | |
| GDGGFCINFPGHYKC | 671 | Q9NS15 | |
| FTCGVHCHGQGKYPC | 111 | Q9NPA1 | |
| HGCSPCDCDIGGAYS | 501 | A4D0S4 | |
| LDGGNPEGCTQCFCY | 176 | Q13753 | |
| TEACHPFVYGGCGGN | 2901 | Q02388 | |
| CFAHPGVCGPGTCYN | 1696 | P35556 | |
| HGCQNILGGYRCGCP | 2626 | P35556 | |
| ACEGDYGGPLACFTH | 656 | P26927 | |
| SCFCVPGYQGRHCDL | 171 | P82279 | |
| YFCDCAPGFLGDHCE | 246 | P82279 | |
| GGCVHDCLNIPGNYR | 96 | Q9NQ36 | |
| VFYIFGGIGCACCPL | 231 | Q9Y2C5 | |
| QCCPGCGYFCTAGNF | 586 | Q9H9B1 | |
| EEICGGHGKCYCGNC | 191 | O95965 | |
| CHGFRDPFECNICGY | 551 | Q9H2S9 | |
| SNLHCLDGCYCPDGL | 416 | Q3ZCN5 | |
| ENCPCGFHGLAYSVG | 441 | Q3ZCN5 | |
| LVFQCGHGACAPCGS | 921 | Q96AX9 | |
| FCGSCGIPVGFHLYS | 136 | O43482 | |
| CLCDPGLYGRFCHLT | 626 | O75095 | |
| GTCRCGPGFYGQACE | 1361 | O75095 | |
| RLCHCPVGYTGAFCD | 196 | P00748 | |
| CPAECAVGGDGHYLT | 561 | A2VEC9 | |
| ECISGHCHCFPGFLG | 541 | Q9UKZ4 | |
| LCGGNGEYEKGHCVC | 566 | Q9UKZ4 | |
| CVSGVCHCFPGFLGA | 586 | Q9NT68 | |
| DCSCLPGCHSGDLYN | 106 | Q6ZVN7 | |
| GCQHFCLPGQESYTC | 136 | P22891 | |
| PCLHGGSCQDRVAGY | 761 | Q8TER0 | |
| CGTGAFHPICGYIDL | 146 | O95025 | |
| CFCCPVGQGYGLTES | 466 | O95573 | |
| PGLLQCVCADGFHGY | 176 | Q6UW56 | |
| FGECCCAPYLPGGLH | 56 | Q9BYD5 | |
| YCLCQPGFSGEHCQQ | 1431 | O75094 | |
| VYLCVCLPGFHGSLC | 1201 | Q8N2E2 | |
| CYGCCQGPEHHRNGG | 196 | Q96HI0 | |
| DCGYPACPENCSGHG | 196 | Q9UQP3 | |
| CGDGVQYFSPCFAGC | 516 | Q6ZQN7 | |
| CHNTPGGFYCICLEG | 91 | Q6UWL2 | |
| RCVQGVCLCHVGYGG | 661 | P22105 | |
| VCLCHVGYGGEDCGQ | 666 | P22105 | |
| HGPCGEYGCDLTCNH | 101 | Q96DN2 | |
| LDSAGYGHICGCCGQ | 951 | O15015 | |
| CGKCGLGYHQQCHIP | 116 | Q5T6S3 | |
| YGNGDCISGTCHCFL | 571 | Q6N022 | |
| CISGTCHCFLGFLGP | 576 | Q6N022 | |
| CLCFAGYTGPHCDQE | 181 | Q9NY15 | |
| GCHDNASCLYVGPGQ | 921 | Q8WWQ8 | |
| GECVSGTCHCFPGFL | 526 | Q9P273 | |
| DCGTCLPGFYEHGDG | 161 | Q93038 | |
| LGGICGFCCSHQQQY | 186 | P30408 | |
| PSRCDGGDGCQYCHS | 261 | Q9H9P5 | |
| PGVCGNCGENVYQCH | 3671 | Q5T4S7 | |
| VNNQPYLCESGHCCG | 31 | Q96G27 | |
| GGSYHCLACESALCG | 3526 | Q15911 |